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CHAPTER I 
INTRODUCTION 
Ischemic strokes are often characterized by abrupt onset of symptoms 
of focal brain disorder, in a distinctive array, denoting the location of 
the lesion, followed by gradual, partial or complete recovery. In other 
instances, within hours of the initial ictus, there are increments of wor¬ 
sening in stepwise progression. The period of increasing disability has 
been called stroke-in-progress, progressing stroke, stroke-in-evolution, 
ingravescent stroke, etc. It is differentiated from completed stroke when 
symptoms and signs have been stable for 48 hours. The temporal boundaries 
of these divisions are arbitrary and sometimes morbidity increases even in 
cases of completed stroke. A number of mechanisms might explain these var¬ 
iations. The stuttering or progressive pattern of increasing impairment 
which characterizes stroke-in-progress, often reflects repetition of the 
elements responsible for the initial event, i.e., recurrent embolus, exten¬ 
sion of thrombus or episodic perfusion insufficiency without vascular 
occlusion. Also, some progression is due to cerebral edema, and edema is 
recognized as a potentially fatal complication of large infarcts. The on¬ 
set of swelling cannot with certainty be differentiated from extension of 
the infarct, on the basis of clinical evaluation. In addition, seizures 
and malfunction of other organ systems may contribute to neurologic impair¬ 
ment. The latter include CHF, cardiac arrhythmias, pneumonia, atelectasis; 
also, renal or hepatic insufficiency, inappropriate ADH activity, glucose 
and electrolyte abnormality and GU infection or septicemia. The effects of 
CNS sedatives or tranquilizers also need to be taken into account. When 
these conditions increase brain malfunction they complicate the recognition 
' 
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of extension of the infarct or development of local edema. 
Another element may be very important. Several investigators have iden¬ 
tified chemical and structural changes consequent to ischemic brain infarc¬ 
tion in animal models of stroke. These studies demonstrate that after cell 
membranes break down, abnormal amounts of dopamine, norepinephrine, serotonin, 
K+, various lipid fractions and other products of altered metabolism con¬ 
centrate in the infarcted tissue. Some of these substances cause vasocon¬ 
striction, others increase_ blood clotting and by these effects may extend 
the area of necrosis. It is reasonable to assume that similar tissue chang¬ 
es take place in human strokes, and that in some instances these substances 
are responsible for progression. Their role in the production of edema has 
not been fully determined. 
While the animal experiments do not reproduce human disease, they have 
opened an area for investigation that had not developed from clinical stud¬ 
ies or post-mortem examinations. As details about the temporal course and 
local effects of these tissue changes are expanded they may have important 
appl ication to patient care. These considerations are pertinent for a 
review of the incidence, patterns and mechanisms of progressing stroke. 
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CHAPTER 2 
HISTORICAL PERSPECTIVE 
Appendix I critically reviews the literature of the last 40 years 
discussing stroke-in-progress.y^e temporal profile of evolving 
stroke has been studied for its diagnostic and prognostic significance. 
The time course has also been examined to better understand the patho¬ 
physiology of stroke; a variety of therapeutic modalities have been 
attempted to halt progression based on changing concepts of etiology. 
Aring and Merritt described the diagnostic usefulness of docu¬ 
menting the temporal profile of an increasing cerebral deficit to 
differentiate hemorrhagic, thrombotic, and embolic strokes.^ The 
stepwise or stuttering time course particularly characterized thrombotic 
(6 11 25 49 50) 
stroke. * * * ’ ' However, embolic stroke may rarely present with 
a similar type of onset. 
Analysis of the time course of progressing stroke has also been of 
special interest in the search for both short and long term prognostic 
indicators. In two early reports Millikan, et aj_. suggested that the 
more rapid the evolution of deficit the worse the prognosis. 
Carter more recently came to a similar conclusion.^0) 
Several neurologists have examined the time course of stroke-in¬ 
progress for insight into the pathophysiological mechanism. Millikan, 
Siekert, and Whisnant noted that the progressing stroke typically follows 
a stepwise time course over many hours and occasionally days.They 
speculated that advancing thrombosis and associated reduction of cerebral 
blood flow, failure of collateral circulation, and neuronal death may 
all be responsible to varying degrees for progression. 
- 
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Focusing on the temporal profile of "ingravescent cerebral in¬ 
farction," Carter noted that fully one third of the population with pro¬ 
gressing stroke evolve between 19 and 24 hours after the onset of 
(21) 
symptoms. ' He suggested that evolution may represent a special stroke 
mechanism, perhaps, of propagating thrombosis, initiation of new thrombo- 
(15 221 tic sites, or repeated distal embolism. * ' Adams, Torvik, and Fisher 
presented similar theories and added that TIA's and progressing stroke 
(25) 
may represent a continuum. ' More recently, Houser, et aJL have re¬ 
emphasized the role of distal embolism in conjunction with failing 
(52) 
collateral circulation. ' Marshall, however, suggested that edema may 
(51) 
also play a major role in early progression.' ‘ Carter and Patel stated 
that old age and hypertension adversely affect the early prognosis. 
The differing theories as to the dynamics of evolution have led to 
a variety of clinical trials to interrupt progression. Conflicting reports 
have been published on the efficacy of stellate block,^>4) anticoagula- 
.. (13,15,16,25,28) .. . . (36) . . . . .. (48) 
tion, carotid vessel surgery,' ' and steroid therapy.' ' 
In interpreting the results of these studies several authors have noted 
the difficulty of evaluating any therapy, since the spontaneous course 
of the process has been only vaguely characterized.(4*5,12,16,17,23,30,32) 
Millikan continued, "the variability of the clinical course of actively ad¬ 
vancing thrombosis makes indispensible the observation of a group of 
untreated patients for comparison of results before final evaluation of 
such treatment.As discussed in Appendix I, many of these studies 
characterized the time course 6f evolution by history only, as the 
patients came under medical observation days or even months after the 
occurrence of progression. Unfortunately, our current understanding of 
the temporal profile of stroke-in-progress relies on these retrospective 
studies.(e,g* 18»24>26>33,34,40,44,50) 
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CHAPTER 3 
OBJECTIVE 
Noting an apparent lack in the literature, a prospective study of 
acute thrombo-embolic strokes was established at the Veterans Administra¬ 
tion Hospital, West Haven, Connecticut. This study was based on the premise 
that frequent, detailed and standardized clinical examinations and inten¬ 
sive care unit monitoring throughout the acute period in a large cross- 
sectional representation of patients who were receiving equivalent care 
might make it oossible to identify the onset of progression, characterize 
its time course, and allow for analysis of causes, perhaps in time to 
initiate appropriate therapy and evaluate its effects on altering the 
natural history of the disease. 
' 
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CHAPTER 4 
CASE MATERIAL 
Between 1972-1975 patients from the New Haven, Connecticut area with 
the initial diagnosis of acute stroke were accepted into the Stroke Study 
Unit intensive care facility. Patients came through the V A Emergency 
Room or in immediate transfer from the two community hospitals in a Shar¬ 
ing Program agreement. Informed consent was obtained from all participants. 
Therapeutic interventions were undertaken as deemed necessary in the judg¬ 
ment of the attending neurologist. 
Only patients with the onset of symptoms clearly less than twenty-four 
hours before admission were accepted into the Unit. To avoid confusing 
the characterization of the temporal profile of evolving stroke, data 
from patients admitted in seizure, post-ictal, or in coma were excluded. 
Records from 349 cases were obtained, including those of thirteen re¬ 
peat admissions to the Unit. At initial examination or subsequent follow¬ 
up by the neurology staff, thirty-two case records were eliminated from 
this study; twelve patients had spinal fluid findings consistent with the 
diagnosis of hemorrhagic stroke--three of these patients came to autopsy 
where the diagnoses were confirmed. Five patients were found to have 
cerebral tumors on angiography or C T scan. In two patients the diag¬ 
noses were changed to hysterical paralysis. One patient's weakness was 
caused by a sciatic nerve lesion. One patient admitted to the Unit was 
in hypoglycemic shock, and another syncopal from the Shy-Drager Syndrome. 
Two patients had suffered head trauma. One patient's stroke was a com¬ 
plication of carotid artery surgery. Another had an air embolic stroke 
status-post placement of a central venous line. One had a stroke as the 
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complication of neurovascular syphilis. One patient had a hypotensive 
stroke following the rupture of an abdominal aneurysm. Finally, four 
patients suffered their cerebral deficits following radiologic contrast 
reactions. 
Data were therefore available from 317 cases of spontaneous thrombo¬ 
embolic strokes. In the data collection and registry the records of four 
patients were incomplete, leaving 313 cases for examination. Among these, 
105 cases of in-hospital progression were identified and form the basis 
of the thesis. 
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CHAPTER 5 
METHODS AND DEFINITIONS 
To identify progression a staff of nurses was additionally trained 
to perform neurologic examinations. They numerically graded each of five 
categories of brain activity, i.e. language, mentation, motor, sensory 
and visual functions. This was done strictly according to the examination 
and grading system detailed in Appendix II. 
The Stroke Care Unit was equipped to monitor four channels of E.E.G. 
and E.K.G. continuously from each of four patients. Systemic B.P. could 
be obtained and recorded automatically at repeated intervals as often as 
required. Central venous pressure and end tidal CC^ measurement and re¬ 
cording capability were included in each patient monitor but were not used 
regularly. 
The graded neurologic examinations together with other clinical and 
laboratory data were recorded on a standard form six to ten times daily 
for each patient during a five to seven day period. The ratings of 
neurologic function were randomly checked for agreement across examiners 
and for consistency. It was concluded that significant change in clinical 
status was reliably indicated when there was a difference of fifteen per¬ 
centage points in any one category or when abnormality in a category was 
added or deleted from the results of the previous examination. Worsening 
of clinical status by these criteria was the basis of denoting progression. 
When such a change was detected by the nurse examiners, the findings were 
confirmed or rejected by the attending physician. If it was determined that 
progression had occurred an attempt was made to establish the cause by 
correlating the general physical and neurologic findings with E E G , E K G , 
N 
9 
B P and other laboratory data. The day of progression was noted with 
respect to the admission day being labeled Day 1. 
The individual case records were then coded and all data transferred 
to keypunch cards for registry at the Yale Computer Center on an I B M 
370 machine. Data were therefore easily retrieved as to the age and sex 
of each patient, and if and when in-hospital progression of signs was de¬ 
tected. Also available were the admission and subsequent systolic and 
diastolic blood pressure readings, the clinical neuroanatomical location of 
the lesion. Noted was the presence of any seizure activity or cardiac 
dysrhythmia during the acute period or other evidence of cardiac impair¬ 
ment. In the registry was any past medical history of diabetes niellitus, 
hypertension or stroke. Finally, for each case any in-hospital thera¬ 
peutic intervention was also recorded, as well as the total length of the 
hospitalization. 
Each patient was categorized in one of five "Admission Classes" 
based on the severity of his deficit at the hour of presention to the Unit. 
The deficit was quantified and followed by strict application of the 
neurological examination and scoring system detailed in Appendix II. 
Using this system five Admission Classes of increasing neurologic impair¬ 
ment were defined: 
Class I —T.I.A.'s i.e. history of a focal neurologic deficit lasting 
less than 12 hours duration. 
Class II—mental status score of 75-100 with other deficits mild to 
moderate (50-75). 
Class III—mental status score of 50-75 or excessive aphasia score 
50-75 or other deficits moderate to severe. 
Class IV--mental status score 25-50 or aphasia score 25-50. Other 
deficits need not be evident. 
V 
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Class V—mental status score 0-25 or^ aphasia score 0-25. Other 
deficits need not be evident. 
Routinely all patients' admission orders included: "1. bedrest 
(flat) 2. monitoring EEG,EKG,BP qh 3. monitoring neuro¬ 
logic status [as outlined in Appendix II]. 4. N P 0 5. no Foley 
catheterization. 6. no sedation, and 7. laboratory work of C B C 
with differential, S M A -18, triglycerides, serology, and a urine analy¬ 
sis." 
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CHAPTER 6 
STATISTICS 
The stroke subpopulation (n = 105) of patients with progressing in¬ 
farct deficits is categorized into a variety of well-defined groups based 
on history and clinical examinations. Selected groups are compared with 
respect to extension day as the quantitative variable. Differences among 
groups are evaluated by a one-way analysis of variance with unequal sample 
sizes. All comparisons are made among those groups which most nearly 
approximate the requirements of a one-way analysis of variance and its use 
of the F statistics. Large values of F in a given comparison indicate at 
least one of the groups is different from the others. In the present study 
comparisons are made at the .05 level of significance. Four of the pa¬ 
tients had extension days of from 11 to 34 and are called 11, while one 
patient had an extension day of from 35 to 50 and is called 12. For the 
purposes of this study, this adjustment is inconsequential since these 
patients appear randomly among the groups selected for comparison. 
The entire stroke population, those with progressing infarct deficits 
(n=105) and the remaining group (n=208), were also classified into a var¬ 
iety of categories on the basis of history and clinical examinations. 
These pairs of classifications are compared by the chi-square test of 
goodness of fit. The calculations throughout this paper are defined by 
the following formulae for the one-way analysis of variance with unequal 
sample sizes: 
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K ni 
2 
SST = ZZ (x^j - x) i.e. total sums of squares 
i=l j=l 
? 2 SST = EZ x .. - T /N where T = zzx.. and N = n-, + n? + ... + . l j l J • ^ n k 
_ 2 
SSB = Z n. (x. - x) i.e. the sums of squares between groups 
S 1 • • 
2 2 n 1 SSB = Z TT/n, - T /N where T. = z x.. 
1 1 1 j=l 1J 
SSE = SST - SSB i.e. the within sums of squares. 
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CHAPTER 7 
RESULTS 
The ages of the 313 total cases ranged from seventeen to ninety-seven 
years with a mean of 66.48 years (a=11.70). Males comprised two-thirds 
of the total population with a mean age of 64.59 (a=10.42). For the fe¬ 
males the mean age was 70.60(cr = 13.28) which is significantly older 
(F=l9.89 > 3.84 at .05 level). There was no statistical difference in 
the mean age of the 105 patients with progressing infarct deficits 
(P.I.D.; x-j = 67.2, a, = 11.39) compared to the 208 non-progressing cases 
(N.P.; X2=66.13), o2= 11.87; F = .6007 < 3.84 at .05 level). 
Table I compares the non-progressing group with the group subsequently 
exhibiting progression with respect to the number of cases in each Ad¬ 
mission Class defined on page 9 at the time of presentation to the Unit. 
As calculated by chi-square analysis, each group presented initially with 
the same spectrum of deficits: 
TABLE I 
ADMISSION CLASS (progressing group versus non-progressing group) 
I II III IV V TOTALS 
PID 7 (8.05) 26 (29.86) 36 (25.50) 25 (26.84) 11 (14.76 105 
NP 17 (15.95) 63 (59.14) 40 (50.50) 55 (53.16) 33 (29.24) 208 
TOTALS 24 89 76 80 44 313 
= 9.096 < 9.488 with 4 d.f. at .05 level i.e. distributions not 
different. 
Overall time course of progression: The day of admission is labeled 
"Day 1." Table II indicates thct progression occurred in over 90% of the 
cases within the first week of admission. The mean day of progression was 
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at 3.61 days with a standard deviation of 2.60. Nearly one-half of the 
cases showed their progression in the first two days; cne-third progress¬ 
ed on Day 2. 
TABLE II 
TOTAL STROKE SUBPOPULATION (n=105) OF CASES WITH PROGRESSING INFARCT 
DEFICITS 
NUMBER OF CASES 
13 
37 
16 
12 
11 
2 
4 
2 
1 
2 
4 
1 
DAY PROGRESSION NOTED 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
x = 3.6095 
o2= 6.75229 
a - 2.5935 
90.48% extended in 7 days or less. 
Sex: Table III tabulates the day of progression for the two sexes 
separately. The sixty-nine males had a mean day of observed progression 
of 3.77 days. The thirty-six females had a mean of 3.31 days. These 
means are calculated to be without statistical difference. 
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TABLE III 
DAY OF PROGRESSION BY SEX 
MALES (69 cases) 
# Day 
7 - 1 
24-2 
11 - 3 
9 - 4 i 
6-5 
2-6 
2 - 7 
2-8 
1 - 9 
1 - 10 
3-11 
1 - 12 
Z x,, = 260 
• J 
Z x2. = 1482 
^ = 3.7681 
C = 3792/l05 
ZZ x?. = 2077 
* J 
FEMALES (36 cases) 
# Day 
6 - 1 
13-2 
5-3 
3-4 
5 - 5 
2-7 
1 - 10 
1 - 11 
Z x2j = 119 
r 4- - 597 
x = 3.3056 
or 1368.0095 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 2602/69 + 1192/36 - C or 5.0617 
SSE = 708.9905 - 5.0617 or 703.9238 
F = 5.0617/1 or .7406 < 3.94 at .05 level 
703.9288/103 
i.e. means not significantly 
different 
Age: The 105 cases of stroke-in-progress were sub-classified into 
five arbitrary age categories. Table IV clearly shows that the majority 
of cases were in patients between ages sixty and eighty years old. Only 
six cases of progression were found in patients below age fifty, reflect¬ 
ing the rarity of ischemic stroke in the younger population. 
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Among all five age categories there was no statistical difference 
in the mean day of stroke progression with the range between 3.067 and 
4 days. 
TABLE IV 
AGE CATEGORIES 
<50 years 50- 59 60- 69 70- 79 80-89 
(6 cases) (18 cases) (33 cases) (33 cases) (15 cases) 
# Day # Day # Day # Day # Day 
1 - 1 2 - 1 3 - 1 4 - 1 3 - 1 
2 - 2 3 - 2 13 - 2 13 - 2 6 - 2 
1 - 3 4 - 3 5 - 3 4 - 3 2 - 3 
1 - 5 3 - 4 4 - 4 5 - 4 1 - 5 
1 - 11 4 - 5 4 - 5 1 - 5 1 - 6 
1 - 8 1/ - 7 1 - 6 2 - 7 
1 -1 2 1 - 8 1 - 7 
1 - 9 1 - 10 
1 - 10 3 - 11 
i—
 <
 
X
 
w
 = 24 Zx2j 72 Zx3j = 114 ZX4j = 123 rx5j = 46 
Exlj =164 lx2 ZX2j = 406 ZX3j = 558 EX2 LX4j = 745 lx?. =204 bj 
*1= 4.0000 x2 = : 4. 0000 x3 = 3.4545 X4 = 3. 7273 Xg = 3.0667 
C = 3792 /105 or 1368, .0095 
EEx?. = 2077 
* J 
SST = 2077 - 1368.0095 
SSB = 24*76 + 722/18 + 1142/33 + 1232/33 + 462/15 - C or 9.3299 
SSE = 708.9905 - 9.3299 or 699.6606 
F * 9.3299/4 or .3334 < 2.48 at .05 level i.e. means not 
699.6606/k00 significantly different. 
Site of infarct: In 88 of the cases of progressing stroke the neuro¬ 
logic examination information was available to clearly localize 
the infarct into one of three broad areas: the right hemisphere, the 
left hemisphere, or the brainstem. Infarcts were twice as common in 
- 
either hemisphere than the brainstem and occurred with approximately 
equal frequency in either hemisphere. The time course of progression 
was statistically the same in all three locations as shown in Table V. 
TABLE V 
SITE OF INFARCT 
CVA RT (33 cases) CVA LF (38 cases) CVA BRA (17 cases) 
HEMISP HEMISP STEM 
# Day # Day # Day 
5 - 1 4 - 1 2 - 1 
9 - 2 16 - 2 8 - 2 
2 - 3 7 - 3 3 - 3 
8 - 4 2' - 4 1 - 4 
3 - 5 6 - 5 1 - 5 
1 - 6 1 - 7 1 - 7 
2 - 7 1 - 8 1 - 11 
1 - 9 1 - 12 
2 - 11 
£xij = 127 £x2j = 122 ZX3j = 54 
EX^ Xlj = 719 lx2 
_ J 
x2 = 
= 570 Zx2 X3j = 272 
X1 = 3.84848 3.21053 x3 = 3.17647 
C = 303*788 or 1043.2841 
ZIX2 . = 1561 
SST = 1561 - 1043.2341 or 517.7159 
SSB = 127/ /33 + 122/38 + 54*717 - C or 8.6871 
SSE = 517.7159 • - 8.6871 or 509.0288 
r 8.6871/2 
509.0288/85 
or .7252 < 3.12 at .05 level i.e. means not 
significantly different 
Admission Class: On the basis of the neurologic examination and 
scoring detailed in Appendix II performed upon arrival to the Stroke 
Unit, each patient was placed into one of five Classes describing in¬ 
creasingly severe deficits. These classes are defined on page 9. 
* 
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The spectrum of impairments at presentation are listed in Table I and Via. 
Most patients presented with an intermediate degree of impairment with 
fewer numbers at the extremes. This distribution of deficit types is 
not different from that of the 208 patients whose strokes did not pro¬ 
gress in the Unit as calculated in Table I by the chi-square test. 
TABLE Via 
ADMISSION CLASS 
I (7 cases) II (26 cases) III (36 cases) IV (25 cases) V (11 cases 
# DAY # DAY # DAY # DAY # DAY 
1 - 3 4 - 1 4 - 1 3 - 1 2 - 1 
2-5 10-2 12-2 9-2 6 - 2 
1 - 7 3 - 3 6 - 3 5-3 1 - 3 
2-10 3 - 4 6 - 4 3-4 1 - 7 
1 - 11 3 - 5 3-5 3-5 1 - 11 
1 - 6 1 - 6 1 - 7 
1 - 7 1 - 8 1 - 12 
1 - 8 1 - 9 
2 - 11 
Zxlj = 51 ZX2j = 81 Zx3j. = 130 ZX4j = 82 ZXr-- = 35 
jx2 = 
£Xlj 429 Ex2 = 
. 2j 
343 Zx2^ = 700 Zx2^ = 400 EX2. = 205 
Xj - 7. .2857 x2 = 3, .1154 x3 = 3.6111 x4 = 3.2800 x5 = 3.1818 
C = 3792/105 or 1368.0095 
ZZx?. = 2077 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 512/7 + 822/26 + 1302/36 + 822/25 + 352/ll - C or 105.6761 
SSE = 708.9905 - 105.6761 or 603.3144 
F = 105.6761/4 or 4.3790 > 2.71 at .05 level ie.e means are 
603.3144/100 significantly different 
In the analysis of the mean day of progression by Admission Class 
group, the seven patients with a history of TIA's only; that is. Class 
I at admission, show a mean of 7.29 days, as contrasted to the means of 
3.12, 3.61, 3.28, 3.18 days for Admission Class II through V, 

19 
respectively. Table VIb evaluates these latter four classes; no statisti¬ 
cal difference is found as to the subsequent mean day of progression 
among patients presenting with permanent deficits, no matter the initial 
degree of disability, whereas those patients admitted with TIA's have a 
significantly later occurrence of progression. 
TABLE VIb 
ADMISSION CLASS WITHOUT CLASS I 
C = 3282/98 or 1097.7959 
ZEx?. = 1648 
* J 
SST = 1648 - 1097.7959 or 550.2041 
SSB = 812/26 + 1322/36 + 822/25 + 352/ll - C or 4.3183 
SSE = 550.2241 - 4.3183 or 545.8353 
r - 4-3183/3 or .2479 < 2.71 at .05 level i.e. means not 
545.8858/94 significantly different 
Length of Hospitalization: 104 of the 105 cases of progressing 
stroke ultimately were discharged. Eight were discharged by hospital 
day ten; twenty-nine were discharged eleven to nineteen days after 
admission. Thirty-three were discharged between twenty and twenty-nine 
days later and thirty-four cases were sent home one month to ninety;- 
nine days after initial admission to the Unit. Table VII illustrates 
that the day on which progression occurred had no bearing on the day on 
which the patient was discharged. 
V 
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TABLE VII 
LENGTH OF HOSPITALIZATION 
1-10 DAYS 11-19 DAYS 20-29 DAYS 30-99 DAYS 
(8 cases) (29 cases) (33 cases) (34 cases) 
# Day # Day # Day # Day 
2 - 1 5 - 1 4 - 1 2 - 1 
4-2 9 - 2 14-2 9-2 
2-3 3-3 4-3 7-3 
2-4 3-4 7 - 4 
6-5 4-5 1 - 5 
2-6 2-7 2-7 
1 - 9 1 - 10 2-8 
1 - 10 1 - 11 3 - 11 
1 - 12 
Exlj = 16 Ex2j = ^ rx3j * 111 IX4. = 149 
“1 j3 36 Ix2^ = 503 lx3. = 563 Ex4j = 971 
x] = 2.0000 x2 = 3.4828 x3 = 3.3636 x4 = 4.3824 
C = 377*7104 or 1366.6250 
EZx?. = 2073 
• J 
SST = 2073 - 1366.6250 or 706.3750 
SSB = 16*78 + 1012/29 + 1112/33 + 1492/34 - C or 43.4678 
SSE = 706.3750 - 43.4678 or 662.9072 
p .43.4678/3 or 2.1857 <2.71 at .05 level i.e. means not 
662.9072/100 significantly different 
Seizure activity: Patients were carefully vatched and monitored 
with E E G for seizure activity. Only eight of the 105 cases of stroke- 
in-progress exhibited seizures in the acute period. These few patients 
had an earlier mean day of progression at 2.25 days compared to the 
mean of 3.72 days for the remaining 97 cases where no seizure activity 
was detected. As calculated in Table VIII the means are not statistic¬ 
ally different, however. 
- 
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TABLE VIII 
SEIZURE ACTIVITY 
NO (97 cases) YES (8 < 
# Day # Day 
9 - 1 4 - 1 
36 - 2 1 - 2 
15 - 3 1 - 3 
11 - 4 1 - 4 
10 - 5 1 - 5 
2-6 
4 - 7 
2-8 
1 - 9 
2-10 
4 - 11 
1 - 12 
= 361 Ex2j = 18 
= 2019 EX2 Ex2j = 58 
3.7216 II CVJ
 
1
 X
 
2.25 
C = 379*7105 or 1368.0095 
Ilx?. = 2077 
• J 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 361 *797 + 182/8 - C or 16.0060 
SSE = 708.9905 - 16.0060 or 692.9845 
p = 16.0060/1 Or 2.5517 < 3.94 at .05 level i.e. 
692.9845/103 means not significantly 
different 
Cardiac Disease: Patients were regarded as having evidence of car 
diac disease if they provided a positive history of angina, infarction, 
failure, use of cardiac medication, prosthetic value or pacemaker 
placement. Also included were patients with pathologic murmurs, cardio 
megaly or failure on chest x-ray, or an abnormal E K G Table IX 
V 
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provides the days on which progression was noted in the fifty-four 
patients with at least one abnormal cardiac finding compared to the 
fifty-one patients without evidence of cardiac disease. The mean days 
of progression were 3.76 and 3.45 days, which are not statistically 
different. 
TABLE IX 
EVIDENCE OF CARDIAC DISEASE 
NO (51 cases) YES (54 cases) 
# Day # Day 
3 - 1 10 - 1 
21-2 16-2 
13-3 3 - 3 
3 - 4 9-4 
5-5 6-5 
1 - 6 1 - 6 
1 - 7 3 - 7 
1 - 8 1 - 8 
2-11 1 - 9 
1 - 12 2 - 10 
2 - 11 
Ex =176 
zxf. = 912 
zx2j. = 203 
Zx2^ =1165 
^ = 3.4510 
C = 3792/105 or 1368.0095 
x2 = 3.7593 
ZEx?. = 2077 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 1762/51 + 2032/54 - C or 2.4926 
SSE = 708.9905 - 2.4926 or 706.4979 
F = 2.4926/1 or .3634 < 3.94 at .05 level i.e. means not 
706.4979/103 significantly different 
Among these fifty-four patients with cardiac disease, forty-eight 
exhibited dysrhythmias while monitored in the Stroke Unit, including 
brady-and tachy-dysrhythmias. Their mean day of progression was 3.33 
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days as indicated in Table X. Again, this is not significantly differ¬ 
ent from the mean day of 3.84 days for those patients remaining in 
normal sinus rhythm. 
TABLE X 
CARDIAC DYSRHYTHMIAS 
NO (57 cases) 
# Day 
5 - 1 
22-2 
8 - 3 
4 - 5 
1 - 6 
1 - 7 
2-8 
2-10 
3 - 11 
1 - 12 
YES (48 cases) 
# Day 
8 - 1 
15-2 
8-3 
4-4 
7-5 
1 - 6 
3 - 7 
1 - 9 
1 - 11 
"ij = 219 
= 1313 
= 3.8421 
£X2j = 160 
i4i -764 
X2 = 3.3333 
C - 379/105 or 1368.0095 
Z£X?. = 2077 
* J 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 2192/57 + 1602/48 - C or 6.7449 
SSE = 708.9905 - 6.7449 or 702.2456 
F - 6.7449/1 or .9893 < 3.94 at .05 level i.e. means not 
702.2456/103 significantly different 
Blood Pressure: The effects of systolic blood pressure on the time 
course of stroke progression was evaluated in several manners. Firstly, 
an attempt was made to correlate the mean day of stroke progression with 
admission systolic and diastolic readings. For the statistical analysis 
' 
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systolic blood pressure effects of 104 patients were classified into 
three ranges with one patient excluded because of an erroneous record¬ 
ing. These arbitrary ranges were labeled "normal" for admission 
systolic values of 110-129 mmHg; "high normal" for systolic readings of 
130-149 mmHg; and "high" for systolic readings greater than 150 mmHg. 
Table XI indicates that of the 104 patieGts so classified wholly 
eighty-one had admission systolic blood pressures greater than 150mmHg. 
In comparing the mean days of extension of deficit among the three 
systolic blood pressure groups, the "high" systolic blood pressure group 
extended earlier at 3.43 days compared to 4.13 days for the eight 
patients with "normal" systolic blood pressures at admission and 4.27 
days for the fifteen patients admitted with systolic readings in the 
130-149 mmHg range. The difference among the groups is noted to be 
without statistical significance. 
V 
25 
TABLE XI 
SYSTOLIC BLOOD PRESSURE 
"NORMAL" (8 cases) "HI-NORM" (15 cases) "HIGH" (81 cases) 
# Day # Day # Day 
4-2 7-2 13 - 1 
1 - 4 2 - 3 26-2 
2-5 1 - 4 14-3 
1 - 11 2 - 5 
1 - 8 
2-11 
9-4 
7 - 5 
2-6 
4-7 
1 - 8 
1 - 9 
2-10 
1 - 11 
1 - 12 
Zxlj = 33 ZX2j = 64 Zx3j = 3^3 
£x2j = 203 zx\. =418 Zx2. = 1440 
X J 
x1 = 4.1250 
?_ 
x2 = 4.2667 x3 = 3.4321 
C = 3752/l04 or 1352.1635 
IEx?. = 2061 
* J 
SST = 2061 - 1352.1635 or 708.3365 
SSB = 332/8 + 642/l5 + 2782/81 - C or 11.1517 
SSE = 708.8365 - 11.1517 or 697.6848 
F = 11.1517/2 or .8072 < 3.10 at .05 level i.e. means not 
697.6848/101 significantly different 
In Table XII similar procedures were applied to the analysis of the 
effect of diastolic blood pressure on the time of progression. Ninety- 
nine of the 105 patients had a clear record of their admission diastolic 
blood pressure. They were classified as "normal" for admission dia¬ 
stolic recordings in the range of 70-85 mmHg; "high normal" for record¬ 
ings in the 85-100 mmHg range; and "high" for admission diastolics great¬ 
er than 100 mmHg. In Table XII again the largest group of patients (39) 
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were in the "high" range. This group has an earlier mean day of ex¬ 
tension at 3.03 days compared to 4.00 and 4.5 days for the "high normal" 
and "normal" groups, respectively. However, there is no statistical 
difference among these three means. 
TABLE XII 
DIASTOLIC BLOOD PRESSURE 
"NORMAL" (26 cases) "HI-NORM" ( 34 cases) "HIGH"(39 cases) 
# Day # Day # Day 
3 - 1 4 - 1 6 - 1 
11-2 9 - 2 13-2 
2-3 6-3 8-3 
1 - 4 3-4 7-4 
3 - 5 4-5 3-5 
1 - 6 1 - 6 1 - 7 
1 - 8 3 - 7 1 - 12 
4-11 1 - 8 
1 - 9 
2-10 
Zx-|j = 108 Zx2j ■ 136 Zx3j = 118 
£X1 j ■ ”0 zx2 = LX2j 770 zx2 = Ix3j 510 
x] = 4.1538 
*2 = 4< .0000 *3 = 3' .0256 
C = 3622/99 or 1323.6768 
ZZX?, = 2020 
■ J 
SST = 2020 - 1323.6768 or 696.3232 
SSB = 1082/26 + 1362/34 + 1182/39 - C or 25.9642 
SSE = 696.3232 - 25.9642 or 670.3590 
F = 25.9642/2 or 1.8591 < 3.10 at .05 level i.e. means not 
670.3590/96 significantly different 
The effect of systemic blood pressure in the acute setting was ex¬ 
amined in another manner. Those patients whose record showed a rise in 
mean blood pressure of greater than 10 mmHG during the week of extension 
' 
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were grouped for statistical analysis separately from patients who did 
not have such episodic hypertension. Table X11 la lists the sixteen 
patients exhibiting this blood pressure elevation phenomenon along with 
their respective days of extension. Their mean day of extension was 
3.75 days, whereas the eighty-nine patients without hypertensive epi¬ 
sodes during the first week of stroke showed a mean day of 3.58 days, 
which is not statistically different. 
TABLE XIIla 
BLOOD PRESSURE ELEVATION (>10mmHg mean bp) 
NO (89 cases) YES (16 cases) 
# Day # Day 
10 - 1 
33 - 2 
13-2 
11-4 
9-5 
1 - 6 
4-7 
1 - 8 
1 - 9 
2-10 
4-11 
3 - 1 
4-2 
3-3 
1 - 4 
2-5 
1 - 6 
1 - 8 
1 - 12 
Exu ■ 319 
IxlJ - 1721 
x, = 3.5843 
Ex2j = 60 
Zx^j * 356 
)<2 = 3.7500 
C = 379*7105 or 1368.0095 
Six?. = 2077 
SST = 2077 - 1368.0095 or 708.9905 
SSB - 319*789 + 602/16 - C or .3725 
SSE = 708.9905 - .3725 or 708.6180 
F = .3725/1 or .05414 < 3.94 at .05 level 
708.6180/103 i.e. means not significantly different 
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Table Xlllb examines the frequency of blood pressure elevations of 
greater than lOmmHg during the week of the stroke in progressing stroke 
compared to the population of 208 patients in the Unit who did not pro¬ 
gress. By chi-square analysis, this phenomenon is shown to in no way 
characterize the population with progression from the stable acute 
stroke group. 
TABLE XIIlb 
BLOOD PRESSURE ELEVATION (progressing versus non-progressing group) 
NO YES TOTALS 
PID 89 (90.91) 16 (14.09) 105 
NP 182 (180.09) 26 (27.91) 208 
TOTALS 271 42 313 
2 
X = .450 <3.841 with 1 d.f. at .05 level i.e. distributions not 
significantly different 
An attempt was made to determine the effects of chronic hyperten¬ 
sion on the temporal profile of stroke evolution. A positive past his¬ 
tory of hypertension, whether or not under treatment was obtained from 
approximately one-half of the patients exhibiting stroke-in-progress. 
The days on which progression occurred in this group of fifty-three 
as well as the fifty-two patients providing normal blood pressure his¬ 
tories are listed in Table XlVa. Those with a past history of hyperten¬ 
sion had progression noted on a mean day of 3.076. The patients without 
such a history progressed with a mean day 4.15 days which js_ significant¬ 
ly later. 

29 
TABLE XlVa 
HISTORY OF HYPERTENSION 
No Hypertension (52 cases) Hypertension (53 cases) 
# Day Day 
5 - 1 
19-2 
5 - 3 
3-4 
9 - 5 
1 - 6 
2 - 7 
2-8 
2-10 
3 - 11 
1 - 12 
Ex-| j = 216 = 1368 
x1 = 4.1538 
C = 3792/105 or 1368.0095 
8 - 1 
18-2 
11 - 3 
9-4 
2-5 
1 - 6 
2-7 
1 - 9 
1 - 11 
2 
Ex£j = 163 E X2j = 709 
X2 s 3.0755 
EEx?j = 2077 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 2162/52 + 1632/53 - C or 30.5232 
SSE = 708.9905 - 30.5232 or 678.4673 
F = 30.-5232/1 or 4.6338 > 3.94 at .05 level 
678.5673/103 i.e. means are significantly different 
It was observed that the group of patients without a history of hyper¬ 
tension included six of the seven cases presenting in Admission Class I; 
that is, patients with acute histories of transient focal neurologic 
deficits of less than twelve hours duration at the time of admission. 
As previously noted in Tables Via and VIb, this group had already been 
identified as progressing later than the other four classes of patients 
presenting with permanent deficits. Therefore, the patients with and 
without a history of hypertension were compared for mean day of exten- 
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sion after excluding those patients presenting with TIA's only. Table 
XlVb shows that these fifty-two with a history of hypertension had a 
mean day of progression of 3.08 days compared to a mean of 3.65 days 
for the group with a negative blood pressure history. The difference 
between these means is without statistical significance. 
TABLE XlVb 
HISTORY OF HYPERTENSION 
(Without Admission Class I) 
No Hypertension (46 cases) Hypertension (52 cases) 
# Day Day 
5 - 1 
19 - 2 
5-3 
3-4 
7-5 
1 - 6 
1 - 7 
2-8 
2 r 11 
1 - 12 
8 - 1 
18-2 
10-3 
9 - 4 
2 - 5 
1 - 6 
2 - 7 
1 - 9 
1 - 11 
lx . = 160 
2J 
lx|. = 700 
x2 = 3.0769 
C = 328*798 or 1097.7959 
Ilx?. = 1648 
* J 
lx= 168 
it*. = 948 
^ = 3.6522 
SST = 1648 - 1097.7959 or 550.2041 
SSB = 168*746 + 1602/52 - C or 8.0770 
SSE = 550.2041 - 8.0770 or 542.1271 
F = 8.0770/1 or 
542.1271/96 
1.4303 < 3.95 at .05 level 
i.e. means not significantly 
different 
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Finally, the effects of elevated blood pressure on the mean day of 
stroke progression was examined by separately evaluating the mean day of 
progression of the few patients whose acute hypertension required treat¬ 
ment in the judgment of the attending physician. Table XV notes that 
the small group of eleven treated patients showed a mean of 2.18 days, where¬ 
as the ninety-one not receiving anti-hypertensive medication showed a 
mean of 3.78 days. These means are not statistically different at the 
,05 level; the difference is significant at the .10 level. 
TABLE XV 
ANTI-HYPERTENSIVE TREATMENT 
YES (11 cases) 
Day 
1 
2 
3 
NO (94 cases) 
# Day 
Exlj * 24 
2 
Ex-j j = 58 
11 
32 
12 
12 
11 
2 
4 
2 
1 
2 
4 
1 
Zx 
zx 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
2j 
2 
2j 
i 2.1818 x« = 
= 355 
= 2019 
3.7766 
C = 379/105 
2 
or 1368.0095 
EZxij = 2077 
1368.0095 
.2 
SST - 2077 - 
SSB = 242/l 1 + 355 7 94 
SSE = 708.9905 - 25.0456 
F = 25.0456/1 
or 708.9905 
- C or 25.0456 
or 683.9449 
or 
___ 3.7718 < 3.94 at .05 level 
663.944/103 3.7718 > 2.76 at .10 level 
i.e. means not significantly different 
at .05 level but significantly different 
at .10 level. 
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History of Diabetes: Patients were selected out of the study who 
provided a seemingly reliable history of longstanding treated or un¬ 
treated diabetes mellitus. In twenty-six of the 105 cases of progressing 
stroke, a positive history was obtained. This group had a mean day of 
progression of 3.96 days. The seventy-nine patients not providing a 
past medical history of diabetes had a mean day of progression of 3.49 
days, which is not statistically different as calculated in Table XVI. 
TABLE XVI 
HISTORY OF DIABETES 
NO (79 cases) YES (26 cases) 
# Day # Day 
9 - 1 
31-2 
13 - 3 
5-4 
10-5 
1 - 6 
3-7 
2-8 
1 - 9 
1 - 10 
2-11 
1 - 12 
4 - 1 
6-2 
3-3 
7 - 4 
1 - 5 
1 - 6 
1 - 7 
1 - 10 
2 - 11 
Zxlj = 276 
ZXjj = 1458 
x, = 3.4937 
Ex2j = 
Ex2J ‘ 619 
x2 = 3.9615 
C - 3792/102 or 1368.0095 
SEX?. = 2077 
SST = 2077 - 1368.0095 or 708.9905 
SSB = 2762/79 + 1032/26 - C or 4.2822 
SSE = 708.9905 - 4.2822 or 704.7083 
F = 4.2822/1 or .6259 < 3.94 at .05 level i.e., means 
not significantly different 704."7083/103 
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Previous Strokes: Thirty-threeof the 105 patients gave a past 
medical history of stroke. This group had a mean day of 4.26 days com¬ 
pared to 3.48 days for the seventy-two patients who were admitted with 
their first cerebrovascular attack. 
Patients showing stroke-in-progress showed the same time course of 
evolution of their deficit regardless of their past stroke history, 
as outlined in Table XVII. 
TABLE XVII 
PREVIOUS STROKES 
YES (33 cases) 
# Day 
5 - 1 
7-2 
5 - 3 
3-4 
7-5 
1 - 6 
2-8 
1 - 10 
2-11 
EXlj = 135 
Zx2]j = 807 
= 4.0909 
C = 3792/105 
ZZx?, = 2077 
* vJ 
SST = 2077 - 1368.0095 or 708.9905 
2 ? 
SSB = 135 /33 + 244 /72 - C or 11.1521 
SSE = 708.9905 - 11.1521 or 697.8384 
F = 11.1521/1 or 1.6460 < 3.94 at .05 level 
697.8384/103 i.e. means not significantly different 
NO (72 cases) 
# Day 
8 
30 
11 
9 
4 
1 
4 
1 
1 
2 
1 
1 
2 
3 
4 
5 
6 
7 
9 
10 
11 
12 
or 1368.0095 
Zx2j = 244 
zx2j = 1270 
x2 = 3.3889 
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CHAPTER 8 
DISCUSSION 
The patients entered into this study came to the West Haven Veteran's 
Administration Hospital Stroke Study Unit intensive care facility from 
the New Haven community hospitals, as well as through the V A Emergency 
Room, thus comprising an apparently adequate demoqranhic representation 
of an acute ischemic stroke population in the qeneral community: For the 
total ischemic stroke population of 313 cases, the mean age was 66.48 
years, with a standard deviation of 11.70 years; the sub-group that show¬ 
ed progression was statistically indistinguishable having a mean age of 
67.2 years, with a standard deviation of 11.39 years, as noted on page 13. 
The age characterization of this ischemic stroke population is in very 
M gg go an 64 661 
close agreement with other studies. * * * ' ' 
The age compositions of the two sexes were evaluated separately. On 
page 13 the females are found to have a mean age of 70.60 years which is 
shown to be significantly older than the mean of 64.59 years for the males. 
(39 a? 66) 
Again, this is in agreement with other studies.' ’ ’ ' Also, perhaps 
typifying the ischemic stroke population, males predominated the number 
of admissions, which has also been remarked upon in the 1iterature. 
19,24,33,40,42,44,55,58) n.. , , . . . +u . 
* Others have de-emphasized the role of sex as 
a major risk factor. 
In the population studied in the Unit, the patients presented with 
a spectrum of severities of deficit. The largest number of patients 
presented with intermediate degrees of impairment. Table I shows that 
the patients subsequently showing progression of their deficit and those 
remaining stable were initially admitted with the same spectrum of stroke 
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severities; degree of impairment at admission is not predictive of 
possible progression. 
The most illuminating observation of the study is revealed in 
Table II: 37 of the 105 cases of stroke-in-progress exhibited progression 
during the second day in the Unit. This quantitatively substantiates 
the "day or two" time course characterizing progression alluded to by 
many of the authors discussed in Appendix I. In the rest of the tables 
the temporal profile of the progressing stroke population is examined 
with respect to factors that might influence stroke evolution. As 
these factors are individually discussed in the following pages, it be¬ 
comes evident that, by and large, the evolving stroke process is truly 
characterized by the time course described in Table II. Furthermore, this 
process is characterized by the independence of this time course from the 
hypothesized control factors. 
First, the influences of sex and age on the time course of evolution 
were evaluated (Tables III and IV); neither seems to affect the time 
course for the population. 
As already mentioned, the severity of deficit at admission was not 
predictive of subsequent progression. The degree of deficit also does 
not influence the rate of progression; (Tables Vla-b). This observation 
is with the noted exception of those patients admitted with a history of 
transient focal neurologic deficits of less than 12 hours' duration; that 
is, TIA cases. They are shown to exhibit progression later on (a mean of 
over a week) in their hospitalization. The possible pathophysiological 
and treatment implications of this finding are discussed in the following 
pages on anticoagulation therapy trials from the literature. 
Others have noted that the length of stay in the hospital stroke 
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patients require is often correlated with the severity of the acute event. ’ 
In another attempt to indirectly evaluate the influence of the severity 
of the insult on the temporal profile of progressing stroke, patients were 
grouped according to the number of days of hospitalization they ultimately 
required (Table VII). Again, by this indirect evaluation, stroke severity 
did not control the time course of evolution. 
SITE: Approximately one fiftw of the localizable infarcts were in 
the brain stem. The remainder were divided equally between the hemis¬ 
pheres. This distribution is similar to that found for ischemic strokes 
(30 33) in general. * ‘ In commenting specifically on the temporal profile of 
progressing stroke, Millikan states: "If the site of the lesion is in the 
carotid system, 18 to 24 hours without progression is ordinarily sufficient 
time to mean that further progression is unlikely and that the patient's 
temporal profile status should no longer be categorized as 'progressing 
stroke.' If the lesion is in brain supplied by the vertebrobasilar sys¬ 
tem, a longer period of time (up to 72 hours) should probably elapse be¬ 
fore the patient is removed from the progressing stroke category and is de¬ 
signed as a 'completed stroke,' since there is a tendency for periods of 
progression to be separated by many hours when the impaired circulation 
is in the vertebrobasilar system."^) 
This study did not reveal differences in time course between the 
hemispheres and brain stem. In lesions of either the posterior or anter¬ 
ior circulations, the greatest number of patients progressed on Day Two. 
With the neurological examination system outlined in Appendix II, includ¬ 
ing serial testing of cortical as well as cranial nerve function, late 
progression, after 48 hours, was detected as commonly in the hemispheres 
as the brain stem. 
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SEIZURES: The presence 0f seizures or post-ictal states at the 
time of admission confused the neurological evaluation of the severity 
of stroke deficit; these records were therefore excluded from the statis¬ 
tical analysis. These case selection criteria weaken any statements 
as to the frequency and role of seizures in progressing stroke. Table 
VIII shows that 97 of the 105 cases of evolving stroke in the study did 
not evidence seizure activity clinically or on electroencephalographic 
monitoring. In this great majority, seizures cannot be implicated as 
responsible for, or a product of, progression. In embolic and especially 
thrombotic strokes in general, seizure activity has been noted to occur 
relatively infrequently. ^ For the few patients having seizures in 
the acute interval, the mean time course was earlier at 2.25 days, but 
the difference was without statistical significance. 
CARDIOVASCULAR DISEASE: The results of this study imply that the 
evolving stroke process is not directly dependent upon a changing cardio¬ 
vascular status of the patient. The group of patients with evidence of 
cardiac disease (Table IX), and specifically the sub-group displaying 
cardiac dysrhythmias (Table X), showed no differences in the temporal 
profile of the evolving stroke from the group without detected cardiac 
abnormalities. 
Several studies have shown that cardiac dysrhythmias are commonly 
observed in the context of cerebral insufficiency.(^-66) obser¬ 
vations will surely become commonplace if stroke intensive care unit 
monitoring becomes more popular.However, dysrhythmic episodes have 
not correlated well with the occurrence of the neurological events.(^6,68,69) 
A simple explanation for the observation of frequent cardiac ab¬ 
normalities in the acute stroke population is that atherosclerosis affects 
' 
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the vasculature of many organ systems. There are numerous reports of the 
high concurrenceof cerebral and myocardial ischemic disease.^9,38,53,60, 
70-73) 
A fascinating alternative explanation for the apparent lack of de¬ 
pendence of the progressing stroke time course on the patients' acute 
cardiac abnormalities is that the cerebral damage causes the cardiac 
abnormalities. This might occur through a variety of mechanisms or 
combinations: 1) the brain infarction might cause the release of 
arrhythmogenic substances; (73,74) ^ the infarction might cause dis¬ 
tant effects upon the central autonomic control center; (75-80) Qr 
the central event might precipitate an actual myocardial infarction^ 
or contribute to the widening of the area of myocardial ischemia and in¬ 
farction. ^8^ Each hypothesis suggests different directions for experi¬ 
mental and clinical evaluation and possible intervention. More careful 
study might reveal new insight into the treatment of both cerebral and 
myocardial ischemic disease. 
The fact that the group with cardiac dysrhythmias progressed with the 
same chronology as did those without dysrhythmias argues against one 
suggested mechanism for stroke progression, namely, that transient sys¬ 
temic hypotensive episodes are responsible for progression.(8’88^ This 
theory is suggested by the finding that cerebral circulation is decreased 
evanescently during cardiac dysrhythmias?88,8^ This has led many authors 
to implicate systemic hypotension as a common precipitating factor for 
(42 88-931 focal cerebral ischemic attacks. ’ ' Others, however, have argued 
that episodic hypotension rarely can be implicated as the precipitating 
event in focal cerebral ischemic events.(20>94-99) 
Whatever role systemic hypotension plays in initiating the stroke 
process, this study of patients with progressing strokes and concomitant 
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dysrhythmias suggests that once the stroke process has begun, it is 
independent to some degree of the effects of blood pressure changes. 
Consistent with this hypothesis, the few patients in this study treated 
with anti-hypertensive medication (Table XV) showed neither an accelerated 
nor a prolonged time course of evolution. Others have safely employed 
hypotensive agents in the acute stroke setting. 
The lack of correlation between the time course of the evolving 
stroke and blood pressure fluctuations is further suggested by the ob¬ 
servation thatanong the patients who exhibited acute elevation in mean 
blood pressure of greater than lOmmHG (Table XIla) there was no notice¬ 
able difference in the temporal profile of evolution. Table Xlllb suggests 
that elevation of blood pressure is as common in acute stroke whether 
stable or under progression. 
Hayakawa and Waltz studied the pathological changes at 48 hours 
correlated with changes in pulse rate (P R ) and mean aorta blood pressure 
(MABP) in 12 tranquilized cats with MCA surgical occlusion and one control 
animal. They concluded that "fluctuation of M A B P and P R did 
not appear to affect the outcome of the ischemic process or the extent 
of the resulting infarcts." No specific comment was made as to the time 
course of evolution of the infarcts. They add, however, that "the moder¬ 
ate increases of M A B P that occurred after MCA occlusion in two 
cats that had small infarcts suggests a possible protective effect of 
moderate hypertension." Clinically, artificial elevation of blood 
pressure has been attempted as a therapeutic intervention. The efficacy 
of pressors to reverse the symptoms of cerebral vascular insufficiency 
has been reported.In primate models, however, artificial blood 
pressure augmentation caused systemic complications of the procedure, 
namely CHF, that negated any possible positive effects. 
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HYPERTENSION: As with vascular disease of other organ systems, the 
presence of hypertension has been identified as a substantial but treat¬ 
able risk factor for the development of a cerebral vascular accident. 
Hypertension has been judged to be present according to different accepted 
upper limits of normal systolic and/or diastolic readings. The blood 
pressure determinations have been made on single or multiple occasions 
in the acute stroke setting or on routine examination. Although the 
definitions of the hypertensive population have differed, there is wide¬ 
spread agreement that hypertension predisposes to stroke.(40,53,55,58,60, 
72,104) 
Admittedly, the stroke population has an older median age than 
(59) the general population and so has a higher incidence of hypertension. ' 
However, it has been found since the time that chronic hypertension could 
be effectively controlled, its treatment has reduced the incidence of 
both hemorrhagic and ischemic strokes. 06) 
The influence of hypertension on the early prognosis of a stroke 
(33) is less clear. Balow, e_t aJL reviewed 100 cases of thromboembolic stroke, ' 
48 had a history of elevated blood pressure and 17 additional patients had 
admission diastolic readings over 90 mm Hg. Among these 65, 42% died or 
failed to improve one month after their stroke. However, little differ¬ 
ence was noted among the 35 normotensive individuals; 46% of them had died 
or failed to improve over the same follow-up interval. Hurwitz, et al., 
likewise could find no increased early morbidity and mortality among the 
23 patients with carotid occlusive disease and blood pressures of greater 
than 140/90 mm Hg compared to the 31 normotensive patients with carotid 
(19) disease. Carter notes in his study of 612 cases of cerebral infarc¬ 
tion that, contrary to his own expectations, he found no difference in 
the death rate at one month between the 392 patients with diastolic 
' 
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pressures over 110 mm Hg or systolic pressures over 200 mm Hg than 
the 220 patients without such hypertension.^0) He discusses hyperten¬ 
sion as a poor prognostic factor only when longterm survival is consider- 
(24 44 571 
ed. This opinion is supported by others. * * ' Fujishima, et al, 
attempted to identify the effects of hypertension on stroke recovery 
in patients with cerebrovascular occlusive disease.Eleven of 16 hyper¬ 
tensive patients were not improved a month after their strokes, whereas 
only one of nine normotensive patients had not improved. Rankin found 
only a slightly increased early mortality rate for stroke patients with hy¬ 
pertension, which was associated with concomitant congestive heart failure. 
In a longitudinal study of 3983 men Rankin found that elevated systolic 
blood pressure, and its upward trend over five years, were associated 
with increased mortality 30 days after stroke. 
Adams showed that both systolic and diastolic blood pressures are 
markedly elevated above baseline in the immediate several weeks after the 
stroke insult. This clinical observation was noted years earlier by 
(21 Gilbert and de Takats. ' Low-Beer and Phear, however, reported that 
blood pressures of stroke victims on admission are reliable for baseline 
assessment. Allowing for this disagreement, the hypertensive popu¬ 
lation for this study was defined by history of elevated blood pressure 
and by elevated systolic or diastolic blood pressures on admission. 
(Tables XI, XII, and XIV). 
78.8% of the 105 cases of progressing stroke had systolic blood press¬ 
ures over 150 mm Hg on admission. Among the general stroke population 
Perkin reported that a similar 73% of patients had over 150 mm Hg.^111^ 
Aring and Merritt found that among patients with thrombotic strokes, 
70% had systolic blood pressures over 160 mm Hg and 52% had diastolic 
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readings over 100 mm Hg. ^ In this study diastolic readings above 100 
mm Hg at admission were found in 39.7% of the cases of progressing stroke. 
Also similar to other studies of ischemic strokes in general was the find¬ 
ing that 50.4% of the patients with progressing stroke provided a his¬ 
tory of hypertension. Mohr, ejt aj_. report that 55% of the patients with 
large artery thrombotic strokes and 40% of the patients with embolic 
(53) 
strokes provided such a history. ' 
In evaluating the role of blood pressure on regulating the time course 
of stroke progression. Tables XI-XIII and XV show that none of the measures 
of hypertension in the acute setting is predictive of an aberrant time 
course of progression. Only the attempt to access chronic hypertension 
by past history (Table XlVa) was shown to prognose a group with an 
accelerated mean time course. This finding would fit well with the ex¬ 
perimental and autopsy studies showing that hypertension accelerates angio- 
(112-114) pathy. ' This would argue for a vascular control mechanism over 
the time course of progression. However, closer review of the hyperten¬ 
sive population with progression shows that among the 52 cases, there 
was only one patient presenting in Admission Class I, whereas the other 
six in this Class were included among those providing no history of hyper¬ 
tension. The delayed time course of these few patients was shown to pro¬ 
vide an explanation for the apparently accelerated course of the hyperten¬ 
sives (Table XlVb). Clearly, for the large numbers of patients present¬ 
ing with permanent cerebral damage, past hypertension and its possible 
effects are seemingly overshadowed by other presumed control factors. 
It is difficult to explain why most of the patients presenting with TIA‘s 
were among those with no history of hypertension. Perhaps it is mere 
chance alone. Curiously, Lindgren has stated that patients with a his¬ 
tory of hypertension have transient attacks more frequently than do normo- 
(12) 
tensives. ' 
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DIABETES: As with the patients with a history of hypertension, re¬ 
ports have shown an association betv/een a history of diabetes mellitus 
(59 115-117) 
and cerebrovascular disease/ * ' This association is even more 
(53 55 impressive if patients with thromboembolic strokes are evaluated/ * * 
(72,118) jn fact estimations of the co-incidence of these two diseases 
may be low, as glucose tolerance testing reveals many cases of covert 
diabetes in the stroke population. Gertler, et al_ found as many as 76% 
of a population with ischemic thrombotic cerebrovascular disease have 
abnormal oral GTT's compared to 22% of the healthy control patients with¬ 
out a family history of diabetes, 32% of the healthy controls with a 
positive family history, and only 39% of the patients with ischemic heart 
disease.^ ^ 
Longstanding diabetes may accelerate the processes leading to an 
ischemic stroke. Frithz and Werner note that diabetes is common in the 
stroke population under age 5oP^ Smooth muscle cell culture experi¬ 
ments suggest a mechanism. Ledet, e_t a]_. found that diabetes serum con¬ 
tains an arterial smooth muscle cell growth factor(s) that they suggest 
leads to angiopathy. (121) In post-mortem study the atherosclerotic pro- 
(122 123) 
cesses are more advanced in diabetics: * ' James implies that possibly 
diabetics are stroke-prone as a result of the adverse effects of the 
disease on the autonomic nervous system regulation of vascular resistance. 
As West discusses at length, it has, of course, been difficult to directly 
relate diabetes and stroke; the high incidence of hypertension among 
diabetics may explain much of the association.^5^ 
In the present study we attempted to evaluate the possiblity that the 
diabetic might show a differing time course of stroke-in-progress; this 
would indirectly suggest that a vascular mechanism is partly responsible 
for the temporal profile. Patients were evaluated for the presence of 
. 
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diabetes by history, since it was felt that the phenomenon of reactive 
hyperglyceremia in the acute stroke setting^ *^) and the in-hospital 
management of blood sugars made laboratory values of reduced significance. 
The results of the study indicated no difference in the time course 
of evolution in the diabetics and non-diabetics. Perhaps this merely 
suggests that the possible vascular regulatory mechanisms in the evolv¬ 
ing stroke patient are as severely compromised in the diabetic as in the 
non-diabetic at the time of presentation with ischemic stroke. 
PREVIOUS STROKES: The patients with histories of previous stroke 
might also represent a group with a particularly compromised cerebro¬ 
vascular system. Table XVII lists the temporal profile of the 33 cases 
of stroke-in-progress who had past medical histories of stroke. Others 
have found a similar percentage of ischemic stroke patients with such 
(19 24 45 531 previous histories. * * * ' Some authors have suggested that this 
history implies a worse prognosis.00,24,30) Qur-|0Usly, in the present 
study, the mean day of progression for these 33 cases was actually later, 
although the slight delay has no significance. 
MEDICAL THERAPY: This research study was not designed to evaluate 
the effect of various modes of therapeutic intervention on the ultimate 
morbidity and mortality of strokes; nor was it established to examine the 
role of such intervention on the temporal profile of the acute event. 
In such a study, of course, strict attention would be given to randomized 
patient selection, uniform dosages of medication, the timing of administra¬ 
tion with respect to initial onset, etc. Furthermore, progression must 
be carefully defined and clinically documented. Millikan has stressed 
that the results of such studies must always be in comparison with the 
study of the natural history of the disease.With these criticisms 
in mind the effect of medical intervention on progressing stroke will be 
reviewed in the literature. 
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Medical therapy trials have primarily been directed toward halting 
edema formation or the ongoing clotting mechanisms. Both clinical trials 
and animal experiments have been carried out to alter progressions 
well as investigate the pathogenesis of evolving stroke. 
STEROIDS: The role of edema, or at least its amenability to the steroid 
therapy, is not apparently major. In a variety of animal models of 
ischemic infarction, steroids have been shown to be disappointingly in¬ 
effective in altering the mortality and morbidity.(126-129) approp_ 
riateness of these various models for deriving inferences applicable 
to the clinical setting is discussed in an excellent review article. ^0) 
In the study of steroids in the acute clinical setting of a stroke, Bauer 
and Tellez found steroids to be without effect on acute morbidity. 
The autopsy review of Ng and Nimminnitya provides a possible explanation. (^1) 
Edema may be without major effect on the patient's course, except in the 
case of massive infarct. However, this massive edema may be little affect- 
(132) 
ed by steroid administration. ' 
In Shaw's study of fatal stroke of sudden onset, involving the MCA, 
edema with midline shift was the common finding in patients dying in the 
(133) first week. ' Notable in their data is the observation that the rate 
of change of brain volume is greatest in the first 2 days after the 
initial onset of symptoms in these fatal strokes. Lee, et^ al_. studied an 
animal model of acute stroke and provided a similar picture.Describing 
the neurological deficits arising after occlusion of the MCA in the cat, 
they noted that the clinical presentation was quite uniform in temporal 
profile with the maximum deficit coming on day two after occlusion. 
This coincides with the time of maximum tissue edema. ^4) Spontaneous 
resolution of the edema is noted to begin 3 to 5 days after occlusion 
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in the surviving animals. In the primate model of MCA macroemboli¬ 
zation, a similar temporal picture of increasing and decreasing edema is 
noted.^6) whether this seemingly steroid-independent edema plays a 
major role in causing the progressing stroke picture or is merely a con¬ 
comitant epi-phenomenon remains unanswered to date. Investigation of the 
brain tissue's inherent mechanisms for the production and elimination of 
this edema fluid may guide future therapy. 
ASPIRIN: The institution of aspirin therapy in the acute setting has 
theoretical support. Mielke, et^ al_., have shown that the onset of pro¬ 
nounced anti platelet activity occurs within hours of the ingestion of 
even small doses of aspirin. ^7) Further, Swank and Bartsch have re¬ 
viewed the experimental evidence that platelet clumping in ischemic regions 
causes spreading of the ischemia through embolization into the local 
microvasculature.^8) $UCh embolization to leptomeningeal vessels from 
a slow-growing thrombus source was suggested on clinical grounds by 
(52) Houser, _e_t al_. 1 to explain progression; fresh small vessel platelet 
aggregates in the context of progressing stroke have been found frequently 
(42) 
at autopsy. ' Alternately, Watts' experiments using autologous clot 
in dogs suggests that the release of chemical substances by platelets may 
widen the margin of ischemia by local vasospasm.^9) Serotonin may well 
be such a substance. 
Platelets have a suggested role in accelerating atherosclerotic 
plaque formation.For several years platelet-fibrin emboli have 
been generally accepted as the common agents of TIA's. The useful¬ 
ness of anti-platelet drugs to prevent TIA's and strokes is currently 
under intensive investigation and the subject of several review articles. (143-145) 
These studies examine stroke prevention. They do not elucidate the possible 
role of continued platelet aggregation in the context of stroke-in-progress, an 
area for further study. Perhaps, the hypothesized local platelet accumulations. 
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or the numerous substances they release, are actually immune from or 
otherwise overwhelm any possible aspirin effects.^6,147) may ^ 
beneficial to evaluate agents that counteract the effects of these re¬ 
leased substances in the search for a method to halt progression. 
ANTICOAGULATION: The literature does contain studies suggesting that anti¬ 
coagulation favorably alters the natural course of progressing ischemic 
stroke. An early report by Fisher stimulated interest in anticoagula- 
(13) tion. He provided a personal series of the reversal of progressing 
stroke in 11 of 14 patients at the time oral or intravenous anticoagulant 
medication was added to their treatment programs. Furthermore, for unclear 
reasons, five of these improving patients had their anticoagulation therapy 
interrupted; three of this group subsequently deteriorated. He contrasted 
these encouraging results with the disappointing results found uniformly 
among patients who presented with completed strokes. Of course, this is 
a small, personally selected series without adequate controls. 
Shortly after Fisher's report was published, several other series 
came out, again supporting the use of anticoagulants in the context of 
(14 1R ?1 ?? oo 14ft) 
progressing thrombotic and also perhaps embolic stroke. ’ * * * * ' 
Based on these earlier studies and their own clinical experiences, several 
neurologists have more recently affirmed the belief that anticoagulants 
are often indicated to reduce mortality and arrest the progress of evolving 
(149-151) 
stroke. ' These authors temper their enthusiasm, acknowledging 
that the well-known multi-organ hemorrhagic complications of anticoagula¬ 
tion therapy severely limit patient selection. Adams and Victor simply 
state their own view of anticoagulation: "Anticoagulants also may halt 
the advance of a progressive thrombotic stroke, but not in all cases. In 
deciding whether or not to use anticoagulants, one faces the question of 
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where in the course of the stroke the patient stands when he is first 
examined. Will his course be benign or disastrous? And . . . there are 
no reliable rules for predicting this at the present time."^2^ 
Analysis of the data presented in Tables VI a-b shows that only those 
patients presenting to the Unit with TIA's had a significantly delayed 
mean time course of progression compared to those presenting with permanent 
deficits of any severity. Only a very few patients among those admitted 
in Class II-IV exhibited similarly late progression. Perhaps among the 
patients presenting with TIA's and a very few presenting with permanent 
deficits, some are manifesting a different mechanism; late progression 
might represent repeated stroke. In contrast the vast majority, those 
evolving within the first two or three days of onset, may be exhibiting 
the time course of evolution of actual cerebral tissue infarction. The 
patients exhibiting delayed progression may warrant a special therapeutic 
approach. For example acute anti-clotting therapy may be discovered to be 
a prophylactic measure against repeated stroke but not to be effective in 
the treatment of cerebral tissue under actual infarction. This hypothesis 
would explain the inconsistent effectiveness of anticoagulation to halt 
progression noted in the quotation from Adams and Victor. ^52^ 
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CHAPTER 9 
SUMMARY AND FINAL CONCLUSIONS 
This study was established to characterize the natural history of 
stroke-in-progress in a large population receiving similar care and 
evaluation. Among the 313 prospectively obtained records of thrombo¬ 
embolic stroke, in-hospital progression was observed in 105 cases. In 
this sub-population a characteristic time course of progression was docu¬ 
mented. The mean day of progression occurred at 3.6 days with one third 
of the cases progressing on Day Two. Progression after a week was rare. 
Neither the age nor sex of the patients affected this temporal pro¬ 
file. Furthermore, patients with a past medical history of cardiac ab¬ 
normalities, hypertension, diabetes, or stroke showed no difference in 
time course. Seizure activity and cardiac dysrhythmias in the acute 
setting could not be implicated as contributing to progression. 
The findings in a small group of patients suggested an unusual tem¬ 
poral profile. The group of patients hospitalized with TIA's was 
observed to show progression later than those admitted with neurologi¬ 
cal deficits of any severity. It is speculated that this group manifested 
a different pathophysiological mechanism, such as recurrent embolus or 
extension of thrombus, thus causing repeated stroke. Most patients showed 
evolution within the first two or three days, manifesting the evolution 
of the process of cerebral tissue infarction. It is suggested that the 
temporal profile Of this process is independent of spontaneous systemic changes or 
manipulation. As a corollary, this suggests an explanation for the 
apparent success of the various uncontrolled therapeutic trials reviewed 
in Appendix I: If the therapy were begun on Day Two, progression after 
' >9 
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its institution would rarely be noted, naturally. 
Kennedy, et al_., have argued against the use of intensive care 
treatment of acute stroke, showing that early stroke mortality was 
not improved (153). Intensive care unit monitoring did not reveal any 
factors that might be corrected to alter the time course of evolving 
stroke. On the other hand, within such a unit the progression of 
signs and symptoms could be documented and the temporal profile defined 
in a population. This unit may serve as a model for the future evalua¬ 
tion of therapeutic attempts to alter the changes actively proceeding 
in ischemic cerebral tissue. 
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APPENDIX I 
REVIEW OF THE LITERATURE 
(1935) C. M. Aring and H. H. Merritt discuss progressing strokes in terms 
of the time course being of aid in distinguishing hemorrhagic strokes 
from thrombotic or embolic. In this autopsy series, a progressive time 
course was noted in 18.7% of one hundred-twelve cases of hemorrhage over 
periods ranging from one-half hour to ten days. In the two cases of pro¬ 
gression among the one hundred six thrombotic strokes coming to autopsy, 
the time courses were seven hours and two days, respectively. Only one 
of the twenty-three embolic strokes progressed and over a one day period. (1) 
(1948) N. C. Gilbert and G. de Takats examined one hundred twenty-one 
patients in their study of the effect of stellate block on altering the 
outcome of cerebrovascular accidents. In their evaluation of the natural 
history of strokes, they found twenty-eight of fifty-three cases of throm¬ 
botic strokes had a "gradual onset," as did four of fifty-three hemorrhage 
strokes, whereas all of the fifteen embolic strokes were "sudden." Un¬ 
fortunately. they did not strictly define these time periods of progression. 
Interestingly, they also admit that "some patients with apoplexy improve 
spontaneously" which makes the value of a therapeutic intervention often 
(2) 
unclear/ ' 
(1951) H. C. Johnson and A. E. Walker culled from the literature one 
hundred-one cases of angiographically diagnosed thrombosis of the internal 
or common carotid artery and added six of their own cases. In their 
comment upon the clinical course, they grouped the presentations into: 
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"sudden catastrophic onset" (35%), "slowly progressive course" (25%), and 
"transient attacks" (40%). They also did not clearly define the time 
limits of these three groups. The "slowly progressive" group seems to 
include patients whose attacks spanned months. The "transient attacks" 
group includes cases where the deficits persist for weeks or months, even 
(31 
until another attack supervened.' ' 
(1953) C. H. Millikan, J. S. Lundy, and L. A. Smith critically studied 
the effects of stellate ganglion block in acute focal cerebral infarcts. 
They remark that several authors in the literature note that improvement 
often follows an acute episode as part of the natural history of the 
disease process. They add that in many studies of the popular interven¬ 
tion of the early 1950‘s, the stellate block, "the assumption is made that 
whatever improvement occurred was a result of the procedure and would not 
have happened without the stallate block." They continue to say that 
there certainly is the need for "an article that adequately records ob¬ 
servations made from day to day on a large number of patients having acute 
focal cerebral vascular lesions. Such observations are necessary, as a 
basis for comparison, when an attempt is made to evaluate a new method of 
treatment of this disease. It [is] obvious that a reasonably standard 
technique of caring for and observing the patients should be devised to 
which could be added any 'new treatment' to be evaluated." They do not 
establish such a study in this paper, giving only brief details as to 
the natural history of progression in twenty-nine patients. The onset 
of signs and symptoms is followed over just one day. From this limited 
study, they do conclude that an extremely rapid progression of the stroke 
over three hours or less foreboded a worse prognosis at the two week 
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evaluation time than did a stroke developing more slowly over a full 
day.<4> 
(1953) C. H. Millikan and F. P. Moersch evaluate the time course of pro¬ 
gressing strokes of the carotid circulation in ninety-three patients in 
a follow-up to the previous study. They only describe the population for 
the first twenty-four hours and again conclude that the more rapid the 
development of the stroke the graver the prognosis. They also remark 
that in those patients whose stroke evolves in more than six hours, almost 
one-half show improvement in condition by the end of two weeks. They there¬ 
fore stress that carefully following the acute time course has long-term 
prognostic significance.^ 
(1954) M. Fisher presents data from four hundred thirty-two consecutive 
routine autopsies where he found twenty-eight cases of occlusion of one 
or both carotid arteries. It was noted to often be difficult to distinguish 
these occlusions as thrombotic or embolic. In his brief review of the 
clinical records, he comments that hemiplegia was the typical finding and 
"the hemiplegia came on slowly in a stuttering fashion over a period of a 
day or two." No comment is made as to how common was this "day or two" 
time course among the fatal stroke population nor any suggestion as to 
how common this time course is in comparison to a population not coming to 
autopsy.^ 
(1956)J.Webster, et al_ present clinical data of seventy patients with ar- 
teriographically proven occlusion of the carotid system of whom fifty- 
seven had hemiparesis or hemiplegia. As to time course, they note that 
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fifty of the fifty-seven had an "abrupt" time course without further de¬ 
fining this time limit. No comment is made as to the time course of 
(7) 
evolution of the remaining seven. ' 
(1956) A. A. Glynn presents a retrospective analysis of the recent 
natural history of three hundred-fifteen cases of thrombotic, embolic, 
or hemorrhagic strokes. He notes that 58% of the one hundred sixty-four 
thrombotic strokes evolved "suddenly," within a minute or two; 20% evolved 
in a "gradual" manner, over a few hours to days; while 13% came on during 
sleep and another 9% had an otherwise unknown time course. Among the 
seventy-three cases of hemorrhagic stroke proven by C S F examination 
or autopsy, 62% were "sudden," 18% "gradual" and 20% of "indeterminant" 
time course.^ 
(1956) K. Sastrasin presents sixty-five cases of carotid thrombosis 
demonstrated by arteriogram, surgery, or necropsy. He vaguely discusses 
the onset of symptoms: one class of twenty-four patients presented with 
"a sudden apoplectic attack with or without loss of consciousness." The 
other forty-one had "a progressive onset with intermittent attacks" only 
characterized that nineteen progressed within a three month period and 
(9) the remaining twenty-two between three months to over five years. ' 
(1957) J. Rankin retrospectively analyzes the clinical presentation of 
two hundred forty-eight patients with cerebral vascular accidents. All 
types are grouped together. Of these, one hundred seventy-eight were 
admitted within twenty-four hours of the onset of symptoms. Unfortunately, 
there is no quantitative description of the time course of onset in any 
of these cases. 
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(1957) J. Riishede discusses the onset of symptoms if fifty-six patients 
with thrombo-embolic strokes. Forty-five patients developed their symp¬ 
toms and signs acutely; that is, within five minutes. Three were sub¬ 
acute, in more than five minutes but less than one hour. Eight were 
gradual in development in more than one hour with no upper limit of time 
specified. No comment is made as to the documentation of the time of 
initial onset, the frequency of repeat examination, nor the incidence and 
timing of improvement of signs and symptoms. 
(1958) S. 0. Lindgren presents clinical data on sixty-five arterio- 
graphically and/or autopsy proven cases of occlusion of the internal 
carotid or middle cerebral artery. Of these sixty-five selected patients, 
35% are reported as having an "acute, catastrophic onset of symptoms," 
42% had "transient attacks with no or only slightly persisting symptoms 
after the first minutes or hours" and 25% had a "slowly progressive onset," 
in terms of weeks or months. It is unclear how soon after the onset of 
symptoms these patients were brought under medical evaluation nor when 
their symptoms reached the maximal point, and if and when recovery occurred. 
He does comment that improvement of symptoms in the acute stage usually 
(12) 
starts after about two or three weeks. ' 
(1958) C. M. Fisher studies the use of anticoagulant therapy in the 
stroke-in-evolution. He provides data on fourteen treated and fourteen 
untreated patients. Among the treated group, three patients developed 
their maximal neurologic deficits within "a few days." Seven had steady 
downward courses over one to seven days. The difference in the nature of 
these time courses is unclear. 
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In the fourteen untreated patients, nine developed a severe stroke, 
seven of these within two weeks. Little additional characterization of 
the nature of evolution of these strokes-is provided. No indication is 
made on how the evolving stroke population differs from the total stroke 
population. No indication is made as to how patients were selected for 
treatment nor exactly when the treatment was begun. The comparison, 
untreated cases were chosen because they were not anticoagulant candi¬ 
dates "for various reasons" and so are clearly not to be regarded as 
controls. 
(1959) C. E. Wells restricts his study to the natural history of em¬ 
bolic strokes only. He gives clinical data on fifty-three patients in 
which sixty-three probable embolic events were observed. Although em¬ 
bolic strokes are identified in part by the criterion of suddenness of 
onset, he does comment that embolic strokes may present with a stutter- 
ingly progressive onset. He gives no details as to the time course of 
development of signs and symptoms after embolism other than noting that 
of the fifty-three patients, sixteen died as the result of embolism 
"in an interval of two and one-half hours to two months after onset, 
thus adducing further evidence that cerebrovascular accidents rarely 
(141 
cause sudden death."v ' 
(1959) A. B. Carter constructs a retrospective study of two hundred- 
nineteen patients with probable thrombotic-type strokes to compare the 
effects of stellate block, anticoagulation, and no treatment on the mor¬ 
bidity and mortality statistics over the one year follow-up interval. 
In reviewing the records of these two hundred-nineteen patients, he 
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distinguishes three types of clinical presentation: ninety-two cases 
were "acute," in which the symptoms reached their maximum at once or with¬ 
in six hours, seventy-two cases were classified as "doubtful," wherein 
the time course could not be obtained, and fifty-four cases were of the 
third type, labeled "ingravescent," in which the stroke evolved over 
more than six hours. This later, progressive group, comprised nearly 
one-fourth of his study population. In the paper, he suggests that this 
group with its more slowly evolving stroke process may well be manifest¬ 
ing a different pathophysiologic mechanism of, say, an extending or frag¬ 
menting thrombus or of the developing of a thrombus in patients whose 
initial symptoms were due to vascular insufficiency without actual clot¬ 
ting. It is to this group of patients with progressing strokes that 
Carter believes particular attention might profitably be given, as they 
may v/ell receive singular benefit from anticoagulation. His small amount 
of autopsy data based on only four patients with ingravescent strokes does 
not point to an obvious, single mechanism; three cases showed complete 
(15l 
carotid occlusion, but the other showed stenosis only. ' 
(1959) E. F. Vastola and A. Frugh examine the efficacy of anticoagulation 
in altering the clinical course of progressing strokes. They subclassify 
presenting lesions as "complete" versus "incomplete" by attempting to 
separate thirty cases of hemiparesis from twenty-five cases of hemiplegia. 
They also pay particular attention to the time after initial onset that 
the patients reached medical evaluation and treatment, realizing that in 
the evaluation of a treatment intervention early initiation of therapy 
may be a most important factor. 
They studied no control patients from which the natural history might 
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be deduced. They do not clearly note how many of the patients with 
paresis progressed to plegia. They admit that no prior knowledge of the 
natural history of progressing strokes makes interpretation of anti- 
coagulation trials difficult. 
(1959) A. J. Luessenhop discusses the role of surgical intervention in 
carotid artery occlusive disease. In his literature review of four 
hundred sixty-four proven cases, he adds twenty-two from his own exper¬ 
ience. This is a highly selected stroke population, as all cases had 
proven carotid artery disease by arteriography, surgical exploration or 
post mortem examination. As this is a compilation of several authors' 
data, it is impossible to know how carefully the time of initial onset 
of symptoms was documented nor how closely and by what criteria changes 
in clinical course were ascertained. In spite of these shortcomings, 
Luessenhop attempts to classify the progression of symptoms into three 
categories, essentially those of Johnson and Walker discussed previously: 
"rapid onset of severe symptoms," "slowly progressive onset of symptoms," 
and "intermittent and immediately reversible." To these he adds a fourth 
group of patients whose histories include "associated symptoms" such as 
headaches, syncope or psychic changes that appeared well before the on¬ 
set of clear motor or sensory deficits. 
Among the four hundred sixty-four cases, Luessenhop identified three 
hundred eighty-four cases of "spontaneous occlusion," where the artery 
occlusion did not occur concomitant with or irmiediately following a cranio¬ 
cervical surgical procedure or trauma. In this literature summary, one 
hundred-eighty of the three hundred eighty-four cases were in the first 
category with the stroke reaching its maximal point within forty-eight 
hours of onset. There is no attempt to evaluate the time course more 
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acutely than within the two day block. Ninety-six patients developed 
their maximal deficit more gradually in more than two days and more fre¬ 
quently over weeks or months. Ninety-seven patients had the intermittent 
picture, where Luessenhop presents their stroke temporal profile in terms 
of the summation of individual episodes occurring over years. The remain¬ 
ing patients are in the associated symptom category; this allows for no 
evaluation of the temporal profile of symptoms and signs. 
Of interest is the section of this paper discussing seventy-three 
patients who develop signs of cerebral ischemia iatrogenically following 
occlusion of the common or internal carotid artery for the treatment of 
an intercranial anneuryms, vascular anomalies or a arteriovenous fistulae. 
The onset of symptoms usually began immediately, as might be expected, 
although there was a delay in many patients with a small peak of patients 
having their episode some twenty hours out from the precisely known time 
of surgical occlusion. In these cases of surgical occlusion, approxi¬ 
mately half had the occlusion removed in an attempt to reverse the neuro¬ 
logic deficit. The time of this intervention after the onset of symptoms 
was not stated, unfortunately. In this group 59% showed complete and rapid 
recovery within minutes to days, and another 16% showed gradual but incom¬ 
plete recovery over the weeks to months of the follow up. In other words 
75% had an improving course. Notable, however, is that in the other half 
of patients in which the surgical occlusion was not removed, 41% made a 
rapid and complete recovery in minutes to days, and 32% made a gradual 
but incomplete recovery over the weeks or months of followup, making a 
similar 73% with a "naturally" occurring clinical improvement. ^7^ 
(1959) W. K. Hass and E. S.Goldensohn report on the clinical and par- 
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ticularly the electroencephaloqraphic findings in the thirty-five 
patients with verified carotid occlusive disease that came to the 
Neurological Institute of New York between 1949 and 1957. The onset of 
symptoms was described as episodic (stuttering) in twenty-two patients, 
slowly progressive in ten and sudden and persistent in three. Their 
time classification is not further elucidated as to when the lesion be¬ 
came maximal, and if and when recovery occurred. Only two of the 
thirty-five patients cameto medical evaluation within the first week of 
the onset of symptoms, so that little reliable information on the natural 
(18) history of early stroke is available fromthis study.v ' 
(1959) L. J. Hurwitz, et_ al_ study the accumulated records from the New 
York Hospital and Bellview Hospital of fifty-seven patients with occlu¬ 
sion of the carotid system as demonstrated by arteriography. The records 
of thirty-three patients were reported as showing a sudden onset of 
symptoms, thirteen were slowly progressive, two had a stuttering time 
course, three had their occlusion demonstrated in the investigation of 
TIA's, five had occlusion demonstrated incidently, and one had no record 
of the type of onset. They do not further define these terms nor give 
information as to the evaluation of the stroke other than to comment 
that there was no relationship between the mode of onset and the severity 
(19) 
of presenting findings. ' 
(1960) C. H. Millikan, R. G. Siekert, and W. P. Whisnant classify the 
clinical presentation of occlusive carotid artery disease in terms of 
four different temporal and perhaps pathophysiologic categories: "(1) 
incipient or impending stroke, (2) advancing stroke, (3) completed stroke, 
and (4) completed stroke with evidence of further activity of the cerebral 
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ischemic process." The second category represents in the stroke-in-pro¬ 
gress. They speculate that several possible mechanisms may account for 
a progressive time course: " (1) stenosis-probably due to advancing 
thrombosis-is present, or (2) collateral supply has failed to provide 
the blood needed, or (3) prolonged inadequacy of supply produces defec¬ 
tive function in more and more brain cells, or (4) a combination of 
these factors is existant." They add that "if thrombosis is progressing 
and causing infarction, worsening may continue by steps for a good many 
hours." Further they note, "in a small number of patients the clinical 
pattern forms gradually or progressively over many days to weeks." They 
also state "it is true, of course, that carotid thrombosis can become 
manifest by the very rapid onset (minutes) of maximal neurologic deficit." 
They note that characteristically: "after cessation of progression 
there may be a number of hours when the patients' condition changes little 
then unless damage has been extraordinary severe, improvement begins. 
This phase of modest improvement is particularly characteristic of in¬ 
farcts produced by thrombosis. The early and continuing improvement so 
common in cerebral thrombosis may be of importance in establishing the 
diagnosis particularly when there has been some reason to suspect the 
presence of a brain tumor or abscess. " 
As this paper attempts to review and evaluate the appropriateness of 
various modes of therapeutic intervention in active strokes, the authors 
quickly comment that the waxing and waning picture of the acute stroke 
and its lack of scientific study makes critical evaluation of a thera¬ 
peutic modality nearly impossible. In their words, "the variability of 
the clinical course of actively advancing thrombosis makes indispensable 
the observation of a group of untreated patients for comparison of 
results before final evaluation of such treatment." Unfortunately, 
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this is only a review article and no data other than anecdotal descrip¬ 
tion is given for examination of the temporal profile of the natural 
occurring stroke-in-progress. 
(1960) A. B. Carter again focuses on the "Ingravescent cerebral infarc¬ 
tion." As earlier this is defined as a cerebral infarction taking more 
than two hours to reach its maximal deficit. In this study two hundred 
ninety-eight cases were examined from consecutive admissions below age 
eighty diagnosed as having a cerebral infarction. Of these thirty-six 
were excluded from the study as embolic strokes, leaving two hundred 
sixty-two thrombotic strokes in the population. Within this group 
ninety patients gave a history of an ingravescent cerebral infarction. 
Carter notes that among the patients excluded from ingravescent class 
because their progression was less than two hours were patients who 
awoke to find themselves paralyzed and those patients who were discovered 
unconscious and could give no history for progression, of course. Clearly, 
then, the frequency of ingravescent strokes is requisitely under-esti¬ 
mated in this study. 
Most interesting is the finding in the ingravescent stroke population 
that the duration of the development of the neurologic lesion always 
fell within a time range of greater than two hours, by definition of 
course, to less than three weeks. Moreover, as is obvious from the 
reproduction of a bar graph in Carter's paper shown below, few patients 
were at the extreme time limits. In fact, in his study, fully one-third 
of the patients reached their maximal deficit in the nineteen to twenty- 
four hour interval. 
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Hours Days 
Time of evolution of strokes. 
This perhaps suggests that there is an intercerebral or intravascular 
event occurring at this characteristic time period to reverse the trend 
in progression. It also perhaps suggests that a therapeutic intervention 
done before this period may have a markedly different influence on the 
final outcome than does an intervention after the maximal deficit has been 
(2i) 
reached and the reversal trend has naturally become dominant/ ' 
(1960) A. B. Carter submits a follow-up study to the last article in 
which he adds the records of the three years previous to those in the last 
study thus making a total of one thousand two cases of stroke of which 
four hundred twenty-five are thrombotic. However, quantitative data is 
only provided for the patients admitted between the years 1956 to 1958, 
as described in the previous study. No discussion is given to the hour 
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by hour progression of symptoms in this article. Little new insight 
is gained into the natural history of ingravescent strokes. Again, 
Carter speculates that the progressing stroke may reflect a special 
mechanism, perhaps a propagating thrombosis, the initiation of new 
(22) 
thrombotic sites, or repeated distal embolism. ' 
(1960) J. Riishede, P. Ottosen and T. Stfndergaard focus on the role of 
surgery in internal carotid artery occlusive disease in thirty-two 
patients presenting with apoplexy over age forty with unilateral or 
bilateral occlusion. The only comment as to the temporal profile is 
that it was "acute or subacute where initial impairment of consciousness 
was noted in half the patients in most instances was characterized by 
somulance, which decreased somewhat during the first hours or days follow- 
in the attack." They have difficulty recommending or speaking against 
endarterectomy, noting that the surgical risk is difficult to evaluate 
(23) in a disease with an "unknown spontaneous course."v ' 
(1960) N. J. David and A. Heyman analyze one hundred consecutive cere¬ 
bral infarction admissions to a V.A. Hospital. They include any patient 
with an apparent thrombotic-type infarction occurring within two months 
of the day of admission; they have clearly limited their ability to 
observe acutely evolving processes. They, in fact, do not state speci¬ 
fically how many patients evolved while under hospital observation. Of 
the one hundred patients, fifty-five were labeled as having a stroke of 
"abrupt onset of symptoms while awake or during sleep." They do not 
elaborate on how abruptness was determined in the sleeping patient. 
In five patients the deficit was noted to develop in a gradual, step¬ 
wise progression over a period of twelve hours to several days. They 
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separately classify four patients who had transient symptoms following 
their initial infarction, as well as nineteen patients whose transient 
attacks preceeded the permanently disabling event. In neither group do 
they provide information as to the time course of development of the 
permanently disabling infarction. 
Another thirteen patients were admitted with transient symptoms only. 
Another four patients were included in which no record of the time course 
of the ischemic event could be obtained. The subsequent results and 
discussion in this paper focus only on the long-term prognosis with no 
(24) 
more comment as to the acute phase of progression or recovery. ' 
(1961) R. D. Adams, A. Torvik and C. M. Fisher retrospectively correlate 
the variably adequate hospital records with the post-mortem findings of 
thrombosis in an atherosclerotic brain artery or in the carotid or 
vertebral system in selected autopsy cases. They describe twelve examples 
of the lateral medullary infarction syndrome due to thrombosis of one 
vertebral or posterior-inferior cerebellar artery where reasonably com¬ 
plete clinical data were available. Reviewing the records, they find the 
deficit developed characteristically over a period of twelve hours to 
seven days. Most typically intermittent at initial onset with continued 
progression for one to ten days. 
In thirteen cases of thrombosis of the basilar artery proven at 
autopsy the thrombotic process had clinically developed over a period of 
two to seventeen days with the tendency toward the shorter range of this 
time span. They note that "in several of these, a neurological symptom 
or syndrome, after a rapid onset, had improved for a number of days and 
then worsened before death." 
■ 
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Among the nineteen cases of unilateral or bilateral internal carotid 
artery thrombosis, six unmistakably showed a progression of symptoms of 
over four days to four weeks. In thirteen cases for which the history 
did not show progression in "several" were cases where the patient was 
found unconscious and so the temporal profile could not be ascertained. 
They feel the progressing time course phenomenon may reflect a special 
mechanism and may be a guide to the search for effective therapeutic in¬ 
tervention: 
"The second well known clinical feature of cerebral thrombosis is 
the relatively gradual development of the complete clinical syndrome 
over a period of hours, day or weeks or in rare instances months or even 
years; and it is this feature of the disease to which we now direct our 
attention. This progression may consist of a worsening of a given 
symptom, i.e., weakness of a limb, over an extended period of time, 
or of the addition of other symptoms referable to a disorder of neigh¬ 
boring structures. A worsening may in fact be followed by improvement 
and then intermittent progression or transient ischemic attacks one or 
several days later. This suggests that the patho-physiological change 
underlying transient ischemic attacks continues to operate during the 
evolution of a thrombotic stroke. In some cases, anticoagulants have 
seemed to smooth out this course, possibly indicating a suppression of 
this mechanism." 
They attempt to further evaluate possible mechanisms at least in the 
fatal progressing strokes by a closer autopsy examination of the throm¬ 
botic material. The finding of the disintegrating leucocytes within the 
clot as well as the finding of endothelial cells and fibroblast invasion 
suggest that the thrombi are at least several days in the making. On 
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the other hand, they provide evidence that embolization distal to the 
thrombus also plays a role. They add that the neural elements themselves 
surely must have a variable lifespan after insult and so allow for an 
(25) 
evolving picture. ' 
(1962) W. G. Hardy, et al_ examine the four year prognosis of one hundred 
fifty-three patients with arteriographically proved carotid artery occlus¬ 
ion. In this study little information is provided on the acute phase, 
as many patients had the onset of symptoms and initial progression out¬ 
side of the hospital. Eighty patients had what is described as a "sudden" 
onset of symptoms with hospitalization occurring one day to sixteen years 
after onset. Only thirty-four patients were seen in the first week and a 
full twenty-one were not seen until a year or more after their stroke. 
Fifty-two patients had an "episodic" onset with hospitalization from 
five days to seven years after the last episode. Most of these episodes 
were apparently TIA's. Fifteen patients had a progressive onset of 
symptoms over five days to a fourteen month course. Only one of these 
patients was seen within ten days of the onset of symptoms. Six patients 
presented to the hospital with associated complaints such as hearing the 
bruit.'26’ 
(1962) C. H. Edwards and N. S. Gordon examine endarterectomy for the treat¬ 
ment of carotid occlusion or stenosis in ninety-seven patients. The tem¬ 
poral profile was assessed by history and not by hospital observation. 
Among these patients, fifty-four patients had a stuttering onset of 
symptoms, thirty had a sudden onset of symptoms, and thirteen had a 
gradual progression. There was unfortunately no definition of these 
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terms, although "stuttering" apparently refers to a history of repetitive 
(271 but transient episodes. ' 
(1962) R. Baker, et aj_ present the outcome of a cooperative evaluation 
of anticoagulation, including the study of one hundred twenty-eight 
patients with stroke-in-progress. No information is provided on the 
actual time course of evolution. The only data provided is that of mor¬ 
tality with no mention as to the time of the occurrence of the final 
event after the onset of symptoms. 1 
(1963) E.S. Cooper, J. Ipsen, and H.D. Brown study the effect of cardio¬ 
vascular disease has on the mortality statistics of 74 consecutive pa¬ 
tients admitted with the clinical picture of an acute stroke. They in¬ 
cluded together thrombotic, embolic, and hemorrhaqic strokes. All pa¬ 
tients were followed for nine months. No information is provided as to 
when the acute episode began before hospital admission. They mention 
classifying patients according to the speed of onset of symptoms but 
do not provide the data in this paper. 
Of these 74 patients, 64% died. No indication is made as to the role 
of the stroke in causing death; except to note that 92.3% of the patients 
admitted in deep coma died, whereas only 67% of the patients admitted 
"alert" were dead by the end of the nine month follow-up period. They 
also correlated increasing fatality figures with the greater severity of 
the paralysis. Patients with "grade 0-1" deficit had a 28.6% fatality 
rate, whereas those with "grade 3" paralysis had an 86.6% rate at nine 
months. 
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(1964) A.B. Carter discussed mortality data in the acute setting of 
a "atheromatous cerebral infarction" (i.e. thrombotic stroke). Among 
the 612 patients studied in a chart review, 159 or 26% were dead within 
(4 5 12) 4 weeks of the onset of the stroke. In agreement with othersv * * ' 
Carter shows that the more rapid the development of symptoms the worse 
the chances for survival. In the study of 219 cases 47% of the patients 
developing symptoms in less than six hours were dead by four weeks, 
whereas only 21% of the patients with strokes evolving over more than 
six hours were dead. Carter is first to admit that his data are not 
ideal in that fully 1/3 of his study population were found unconscious 
or awoke paralyzed and so had unknown time courses of onset. 35% of the 
group were dead at the end of four weeks. In all three groups the peak 
of early death was between the third and tenth day. 
Carter briefly remarks on the stroke morbidity in the acute setting, 
that the earlier the beginninq of recovery the better the longterm prog¬ 
nosis: "If a patient is going to walk again there should be some move¬ 
ment of the legs within a few days of the stroke, and if the hand is 
ever going to be useful, movement of the finger and thumb must appear 
within the first two weeks." These comments are made without the presen¬ 
tation of supporting data.^^ 
(1965) A. Silverstein and S. Hollin discuss the clinical presentation 
of internal carotid artery stenosis or occlusion as contrasted to middle 
cerebral artery stenosis or occlusion, as evidenced by fifty patients 
with each respective lesion demonstrated arteriographically. The clinical 
data for all one hundred patients was obtained from retrospective review 
of their hospital charts. 
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The onset of symptoms was described as quite sudden in forty-five 
patients with middle cerebral artery occlusion and in thirty-six in¬ 
ternal carotid occlusion. In both groups this sudden onset of symptoms 
was frequently followed by rapid improvement but with subsequent inter¬ 
mittent episodes. This was noted in nine patients with middle cerebral 
artery disease and ten patients with internal carotid disease. They 
add that seven of the middle cerebral artery patients and nine of the 
internal carotid artery patients presented with an abrupt onset of 
symptoms with a progressive course. Five patients with middle cerebral 
artery disease and fourteen patients with an internal carotid artery dis¬ 
ease had a gradual onset of symptoms. Unfortunately, they give no in¬ 
formation as to the meaning of these terms. They do not state how soon 
after the initial onset of symptoms these patients came to hospital evalua¬ 
tion. Finally, there is no separation of suspected embolic strokes from 
thrombotic in the tabulation of the mode of onset. Despite these short¬ 
comings, these authors come to the conclusion that middle cerebral artery 
occlusion more often presents abruptly, whereas internal carotid artery 
(31) 
occlusion tends to have a progressive time course. ' 
(1965) R. G. Loscelles and E. H. Burrows retrospectively examine the 
acute clinical course in 59 cases of arteriographically proven stenosis 
or occlusion of themiddle cerebral artery. Among these patients, three 
patterns of onset were discovered: 34 patients had what was called a 
"sudden or apoplectic" development of the maximum deficit; eleven 
patients had a "progressive" course where their condition steadily wor¬ 
sened over a few days; and fourteen patients had had a "stepwise" course 
with points of stability between episodes of progression. The authors 
note that all patients initially developed impairment of consciousness 
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which cleared rapidly--the exact time course not specified--in most pa¬ 
tients who survived.^3^ 
(1966) J. Balow, M. Alter and J. A. Resch review 100 cases of cerebral 
thromboembolism. In all cases the onset of symptoms began within 1 
month of hospital admission; at the time of admission all the patients 
had a stable or improving clinical course. By history only, then, 32 
patients had a sudden onset of symptoms with the maximal neurologic 
deficit occurring within 1 hour. Included in the group, however, were 
all patients who gave a history of discovering their deficit upon 
awakening. 
In the 18 remaining cases, the onset was more nradual, progressing 
to the maximum "after several hours or days." They mention that those 
individuals whose symptoms developed more gradually had a relatively 
higher chance of an improving course at the end of one month compared 
to those in the sudden onset of symptoms group. They give no quantita¬ 
tive data, adding that this conclusion was actually "not statistically 
significant.33^ 
(1966) A. Torvik and L. Jorgensen review the hospital charts of 52 pa¬ 
tients with occlusive disease anywhere in the carotid system, diagnosed 
among 994 consecutive routine autopsies. Of these,forty-one patients 
were symptomatic from the lesion and in thirty-three death was attributed 
to the occlusion. The length of survival from the onset of symptoms 
varied from eight hours to nine years. 1/2 of the patients died within 
the first 20 days. 
On reviewing the histories, four types of onset were distinguished: 
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twenty-seven patients, or fully two-thirds of the cases, had a sudden on¬ 
set of symptoms developing within minutes or "a few hours" and thereafter 
had a stationary or slowly worsening or improving course. 
The second type was labeled "intermittent course," where the history 
was of sudden but transitory attacks occurring before the permanently 
disabling episode. Curiously,only one patient came to autopsy with 
this "characteristic" history for carotid artery disease. 
Three patients had the third clinical course of repeated attacks last¬ 
ing days with complete clearing or only minor residua between episodes. 
The second largest group, comprising six patients, had the history 
of a step-wise progression of accumulating neurologic deficits. Unfor- 
(34) tunately, the time course of the individual "steps" was not described/ ' 
(1966) J. Marshall reviews the natural history of stroke in seventy- 
two patients who are arteriographically proven stenosis or occlusion of 
the internal carotid artery. Among the thirty-two patients with total 
occlusion, eighteen had the history of "completed stroke," meaning that 
a stroke reaching its maximum intensity in less than six hours and there¬ 
after persisting over days or weeks with subsequent improvement usually 
stopping short of complete recovery. Seven of these thirty-two patients 
had a history of "progression," that is, symptoms developing gradually 
over more than six hours with no upper time limit specified. 
Six of these thirty-two patients came to arteriography with a history 
of TIA's and one patient had a history of progressive mental deterioration 
only. 
Among the forty patients with I C A stenosis, sixteen had the "com¬ 
pleted stroke" history. Six had a history of "progression," sixteen 
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had T I A 's only and two in the group had arteriography for asympto¬ 
matic bruits. 
In this retrospective chart review little clinical detail is avail¬ 
able as to the acute time course of neurologic changes. Marshall notes 
only that one patient with occlusion and four patients with stenosis 
died in the "immediate" period without stating the exact time relation¬ 
ship of death to the initial onset of symptoms, admission to the hos- 
(35) 
pital or date of arteriography. ' 
(1966) W. M. Lougheed, R. G. Elgie and H.J.M. Barnett report on the art- 
eriographic and clinical findings on 109 patients undergoing carotid 
endarterectomy. Eight patients with internal carotid artery occlusion 
and four patients with stenosis were described as having a gradual, 
step-like progression of focal cerebral symptoms over a period of "hours 
or occasionally over a few days." In this paper they conclude: "The 
likelihood of restoring flow and the benefit to individual patients are 
maximal during the first few hours to days after occlusion of the artery. 
Although the best results will be obtained in patients presenting with 
transient ischemic attacks or strokes-in-evolution, surgical reconstruc¬ 
tion should be attempted in some patients with completed strokes." Yet 
they also admit "The postoperative assessment of patients with completed 
strokes is extremely difficult in view of the natural history of improve¬ 
ment without definitive treatment in patients surviving the initial insult." 
They, however, do not give any details as to the time course of evolution 
or recovery of the individual cases studied. Surely, the natural history 
of progressing stroke is even less clearly known.^36^ 
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(1967) C. M. Fisher and A. Pearlman present sixteen cases of cerebral 
embolism. Twelve of these cases were evaluated pathologically. The 
cases were collected over some twelve years for their unusual feature 
of a gradual or stepwise onset of symptoms in all sixteen cases. The 
authors speculate that this unusual time course in embolic strokes may 
reflect the effect of emboli in the bloodstream as they "gyrate, twist, 
and change shape conceivably straddling bifurcations temporarily or par¬ 
tially entering the side branches of a vessel,"or by, "the arrest of em¬ 
bolic material,. . . resulting in cerebral ischemia which was reversed 
by virtue of collateral blood flow entering the compromised territory." 
This paper is only a series of case reports primarily with autopsy follow¬ 
up data, so no accurate determination as to the incidence of progressing 
(37 \ 
embolic stroke can be made. ' 
(1967) P. Bradshaw and E. Casey reviewed the records of forty-seven 
patients, forty-five of whom were under age sixty-five, with arterio¬ 
graphy demonstrated lesions of the internal carotid artery. Of these 
patients selected for arteriography, thirty-three had a history of TIA's. 
Eleven had a sudden stroke. Three had ingravescent hemiparesis "which had 
increased during a period of twenty-four hours or more." No other 
comment is made as to the initial history of the stroke in this selected 
population. 
(1969) J. Marquardsen retrospectively studied the clinical course of 
769 patients with any type of cerebral vascular accident. 80% of these 
patients were under hospital observation within twenty-four hours of the 
onset of symptoms. Only 8% are included in the study who were seen after 
three days from the beginning of symptoms. 
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In this study, 40.3% of the males and 31.8%of the females died with¬ 
in the first week of symptoms. A full 65% of the patients admitted in 
deep coma died within the first twenty-four hours of onset. He adds 
with regards to predicting prognosis that "A higher degree of validity 
is, however, obtained when changes in the state of consciousness during 
the first twenty-four hours are taken into account." He noted, when 
gradually increasing impairment of consciousness v/as observed in thirty- 
four patients who were initially semi-comatose or drowsy; only two of 
these survived the first three weeks. Similarly, there were only four 
survivors among thirty patients who, after having been fully conscious 
on admission, became drowsy, or lapsed into coma during the first day 
in hospital. A somewhat lower mortality was found in the group of 
somnolent or semi-comatose patients in whom improvement of conscious 
level took place shortly after admission; eleven of twenty-eight such 
patients survived. For those who were in deep coma on admission, how¬ 
ever, the prognosis remained grave even if some improvement took place 
after admission; survival was observed only once in eight cases of this 
category. The sole survivor was a seventy-two year old female who was 
admitted immediately after a convulsive seizure; she regained conscious¬ 
ness a quarter of an hour later and became well after a few days. 
It should be noted that these early mortality data must have in¬ 
cluded many cases of hemorrhage. In fact, of the patients who were either 
comatose or semi-comatose on admission or lost consciousness during the 
first twenty-four hours; 153 came to autopsy. Of these, 115 cases were 
hemorrhagic strokes. No details on the time course of development of 
morbidity nor on the factors that influence its development and predic¬ 
tion of long term prognosis are presented. 
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(1969) G. C. Flora, T. Omae, and K. Nishimoru present a paper of the 
"clinical profile of the stroke patient" in U.S. and Japanese populations 
The patients were selected with apparent thromboembolic type strokes 
occurring within one month of hospitalization. In remarking on the 
acute time course, they note that 84% of the 145 U.S. patients had an 
acute onset; the remainder had a gradual onset. In the Japanese popula¬ 
tion, 63% of the 123 patients had a sudden onset; and the remainder were 
gradual. These two temporal categories were not clearly defined. The 
time course assessment was obtained by history only. They state that "In 
a large number of patients an accurate history of the patientdstate at 
the onset of the cerebrovascular accident was not available* They note 
that one fifth of the patients had their stroke occur during sleep. 
(1969) S. Heyden and C. J. Gerber discuss the clinical course of pro¬ 
gressing strokes in their review article on atherosclerotic cerebrovascu¬ 
lar disease. They declare, with no literature or data substantiation, 
that: "In progressive Stroke the neurologic deficit develops gradually 
in a period of hours to days. In most cases, careful observation reveals 
that there is a saltatory accretion of symptoms. Less commonly, the 
evolving stroke proceeds smoothly and gradually without periods of sta¬ 
bilization between episodes of impairment. . . The importance of iden¬ 
tifying stroke in its early evolution rests on the fact that therapy may 
be effective if instituted immediately after onset." 
These authors would clearly agree that the freguency and characteriza 
tion of the timecourse of progressing stroke need investigation as do 
the possible factors that predispose and/or influence the outcome of 
this type of stroke, if rational therapeutic intervention is to be made 
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(41) 
at an appropriate time. ' 
(1969) L. Jorgensen and A. Torvik re-examine the data of their 1966 
study of 994 consecutive routine autopsies. This paper focuses on the 
clinical course as well as pathology in 320 patients with ischemic 
cerebrovascular disease. In this retrospective review of the records of 
patients coming to autopsy, the most common temporal profile of stroke 
symptoms was that of sudden onset developing over seconds to "a few 
hours." This course was noted in 83.3% of the 171 stroke cases for 
which adequate clinical records were available. These records were 
obtained in 126 patients. This sudden onset to maximal deficit was par¬ 
ticularly characteristic of the autopsy verified embolic strokes, where 
it was noted in fifty-seven of the fifty-eight cases examined. 
Of the thirty-two cases of non-sudden onset of symptoms, only one 
was thought to be embolic. On autopsy thrombi were found in eighteen 
cases of which only nine were at extracranial sites. All thirty-one 
non-embolic cases had evidence of severe atherosclerosis of the cerebral 
arteries. The authors intimate that these findings argue against the 
(42) frequent use of surgical intervention in progressing strokes. ' 
(1969) J. Gilroy, M. L. Barnhart, and J. S. Meyer appraise the use of 
Dextran 40 in the treatment of acute stroke in 100 patients. Their popu¬ 
lation had the acute onset of the stroke twenty-four to seventy-two hours 
prior to admission without further worsening at the time of admission. 
These patients, then, apparently had completed strokes at the time of 
therapeutic intervention rather than "progressive" strokes, as stated. 
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In this study all patients with systolic blood pressure recordings 
over 180 mmHg, cardiac disease, or renal impairment were excluded from 
the study, surely making this a rather atypical stroke population. 
Fifty-four patients received no Dextran 40 and served as controls. At 
the ten day follow-up reevaluation thirty-one of this group were improved, 
(43) 
eight were unchanged, seven were worse, and eight had died. ' 
(1971) J. Acheson prospectively follows 500 patients over a mean period 
of 4.6 years. Unfortunately, only 338 patients were observed as in¬ 
patients of whom only ninetz-six were emergency admissions, so that the 
comments on initial onset of symptoms apparently are by history only. 
Acheson has some information regarding the mode of onset in 394 patients. 
Of these, 326 or 82.7% had the maximal deficit at the initial onset of 
the stroke. Of the remaining sixty-eight, twenty-six were noted as 
developing their stroke between six and 24 hours, 31 between one to 
two days and the remaining eleven in longer than two days with no upper 
limits specified. Using the chi-square test comparing the mode of evolu¬ 
tion with the degree of disability assessed at three, six, and twelve 
month follow-up; Acheson found no significant association. She makes no 
comment as to age, sex, cardiac, or other factors that might have been 
(44) 
an influence on mode of onset. ' 
(1973) A. Brodal presents a description of his own stroke which interest¬ 
ingly had a progressive time course with the maximal deficit more than a 
day in coming on and with subsequent early recovery obviously evident 
by the fifth day.^) 

(1973) R.B. Bauer and H. Tellez evaluate the use of dexamethasone in 
ischemic stroke patients who had the initial onset of their deficit less 
than forty-eight hours before admission and who all presented with some 
impairment of consciousness. In this randomized, double-blind study a 
total of twenty-six patients were in the placebo group and served as 
controls for monitoring the natural history of the ischemic process. In 
this study, involving so few patients; the placebo group, by chance, re¬ 
ceived a larger percentage of patients with more severe presenting de¬ 
ficits. In an attempt to adjust for this unevenness the authors present 
their data of daily neurologic evaluation scores for the treated and 
control groups after excluding all patients admitted semi-comatose. 
Therefore, the data presented is based on only twenty selected control 
patients. By the end of two weeks, fifteen of these patients had im¬ 
proved or were unchanged. Five had deteriorated; three of whom had died. 
Unfortunately, the day to day data is presented as group averages for 
the control and treated patients so that no insight is given as to the 
natural history of evolving stroke in the individual patient. 
(1974) S.O. Shafer et al_ evaluate the stroke morbidity in 524 consecu¬ 
tive stroke admissions. The patient population was composed of Black 
inner-city residents. The first sentence of this article states: "on 
the first day after stroke, the chances for survival can be reckoned 
quite reliably." They do not explain how such predictions can be 
accurately made nor further comment on the temporal profile of the 
patients during this apparently helpful acute period for prognostic 
(47) 
evaluation. ' 
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(1974) J. F. Toole and A. N. Patel state without providing the 
supporting data: "In most instances, the neurologic deficit resulting 
from a cerebral infarct reaches its maximum within the first seventy- 
two hours. Old age, hypertension, coma, cardiorespiratory complications, 
anoxia, hypercapnia, and neurogenic hyperventilation are additional adverse 
prognostic factors, especially in the first forty-eight hours after 
cerebral infarct. In rare instances the development of massive cerebral 
edema leads to progressive deterioration and sometimes death. 
Some improvement may be apparent after the first two weeks and by the 
end of twelve weeks the maximum recovery will be reached in most cases. 
With noticeably few exceptions, no further recovery should be expected 
after six to nine months." 
These are statements of clinical impressions that clearly deserve 
further examination and quantification in order that the validity of 
assessing prognosis in the acute setting can be evaluated. Also, the 
early adverse prognostic factors must be separately evaluated in order 
to ascertain their relative influence and the value of possible thera¬ 
peutic manipulation. 
(1976) C. M. Fisher writes a chapter on the natural history of middle 
cerebral artery trunk total occlusion based on the analysis of forty 
cases. No information is given as to the system of collection or account 
of the reliability of detail of these records. He does note that in 
thirty-eight cases the MCA occlusion was confirmed arterioqraphically 
and pathogically in two cases. 
; 
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Focusing on the acute natural history of M C A occlusion, Fisher 
states, without specific data, that embolic M C A stroke "probably 
always develops in a few minutes and without prodromal warning." He 
adds, "a few instances of embolism have been preceded by several TIA's 
in quick succession over a short period (eg. eight hours) but not over 
days or weeks." He qualifies his statement additionally: "An occasional 
embolic stroke appears to have shown as much as six hours of slow pro¬ 
gression before realizing its peak." 
Among the forty cases in this study, twenty-three were thought to 
be thrombotic M C A strokes on the basis of known long occlusion of 
the artery or by post-mortem study. Of these cases, 65% had prodromal 
TIA's and 15% had a step-wise progression of symptoms. In other words 
41% of the cases presented with early symptoms that gave the physician 
some time to attempt medical or surgical intervention. In the pro¬ 
gressing stroke Fisher states: "When a persistant stroke appeared and 
began to evolve in a step-wise or progressive fashion, the duration of 
progression to a peak was two or three days; a brief period which 
would demand quick decisions if surgical intervention were entertained." 
Clearly, the need to identify a progressing stroke early and predict the 
severity and time of maximal deficit are of great importance, as is the 
(491 isolation of possible factors influencing the time course of events/ ' 
(1976) H.R. Jones and C.H. Millikan review the records of the patients 
who were admitted to the Mayo Clinic Cerebrovascular Hospital Service 
between 1967-1969 with the diagnosis of carotid system infarctiion. 
Only patients admitted within thirty-six hours of the initial onset of 
symptoms were included in the study. Patients with a history of TIA's 
. 
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only, collagen vascular disease, bacterial endocarditis, or syphilis 
were excluded. The patients' clinical courses were recorded "daily or 
more often" with the results for the first week graphed as severity of 
deficit vs^ day after admission. 
Of the 220 consecutive ischemic strokes reviewed, 179 had carotid 
system lesions. In examining the clinical course over the first week 
39% of these patients were unchanged. 35% of the patients had gradually 
improved. 19% had a progressing neurological deficit from the onset 
which stabilized within two days. 4% had the course of significant 
late worsening, after 48 hours of a stable or improving course; 3% of 
these cases of acute carotid system infarction had a remitting-relapsing 
course in the first thirty-six hours. 
To focus on the thirty-four patients (19%) with a progressing 
course, they note that this included patients with focal and/or 
general worsening of symptoms. Twenty-one patients showed progression 
focally of whom seventeen had the loss within the first "few hours." 
The remaining thirteen of the total thirty-four had a deterioration in 
level of consciousness, beginning at the onset in eleven and within the 
first forty-eight hours in all thirteen. The distribution of times over 
which stabilization occurred was not delineated. There was no evaluation 
made of the age, sex, cardiac, bloodpressure, etc. make up of this group 
of progressing stroke patients that might distinguish it from the non¬ 
progressing population. 
Eight cases of progressing stroke patients came to autopsy; in seven 
there was cerebral infarction with edema, convolutional flattening mid¬ 
line shift, uncal notching, and secondary brainstem hemorrhage. In 
this study these authors agree with their old opinion that the rapid 
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onset of symptoms in less than three hours forbodes a poor prognosis for 
recovery of function.^0) 
(1976) J. Marshall writes a chapter titled "Stroke-in-Evolution," where 
he speculates several mechanisms whereby a stroke "unfolds slowly over 
several h,ours or even one or two days,...most commonly in a series of 
distinct steps, the exact time of each deterioration being readily recog¬ 
nized." He speculates on several mechanisms: Increasing thrombus for¬ 
mation on a atheromateous plaque may interfere with the blood supply 
beyond the ability for collateral compensation. Edema may cause a 
gradual increase in symptoms. He says this mechanism should be suspected 
when the temporal profile is of abrupt onset of a stroke, followed by a 
period of stabilization for one to two days after which there is a 
deterioration of both local and general signs. If gradually developing 
ischemia provides,at least in some cases, a totally independent mechanism 
for progression of the stroke than does edema formation, then these hope¬ 
fully might be clinically distinguished and so therapy guided more 
logically. ^ ^ 
(1976) O.W. Houser, e_t aj_. review the arteriographic findings in seven¬ 
teen cases of progressing stroke of 6.6% of the 256 surgical cases of 
carotid artery occlusive disease. Curiously, fifteen of the cases in¬ 
volved the left hemisphere. 
From hemodynamic measurements made at surgery correlated with the 
arteriographic findings, these authors speculate a pathophysiologic 
mechanism for the progressing stroke temporal profile. They suggest that 
in the context of decreased arterial perfusion and inadequate collateral 
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circulation, progression may occur when the major contribution of lepto- 
meningeal vessel perfusion over the convexities becomes impaired secon- 
(52) 
dary to embolization from the diseased carotid system. 
(1978) J. P. Mohr, et_ al_, present a prospective study of 694 hospitaliz¬ 
ed patients. The authors do not clearly state the relationship between 
the onset of stroke symptoms and the time of admission. In the 232 cases 
of large artery thrombotic stroke, 40% had a "sudden" onset, 34% had a 
"step-wise or stuttering" course, 13% had a "smooth or gradual" course, 
and another 13% had a "fluctuation" from normal to abnormal. 
Of the 213 cases of diagnosed embolism only 79% had what was des¬ 
cribed as sudden onset of symptoms. 11% had a stuttering or step-wise 
progression, 5% had a smooth or gradual increase of symptoms, and another 
5% had a fluctuating course. This suggests that "thrombo-embolism" may 
at times be a safer clinical diagnosis to provide. 
Of the 115 cases of cerebral hemorrhage the onset was sudden in 34% 
of the cases, stuttering in 3%, and smooth or gradual in 63% of the 
cases. After admission 56% of the patients deteriorated of which one fourth 
died suddenly. The timing of this event after admission was not 
specified. 
131 patients had small, deep brainstem infarcts, i.e. lacunes. 38% 
of these patients had a sudden onset of symptoms, 32% had a step-wise 
or stuttering course, 20% had a smooth or gradual course, and 10% had 
fluctuations. This is similar to the temporal distribution noted in 
the large artery thrombotic stroke patients. This paper is a prospective 
study of a large number of patients. Unfortunately, the authors do not 
clearly state the meaning of their descriptions of the onset of symptoms. 

85 
They also do not provide any information on the course of these patients, 
throughout their hospital stay, and its relationship to the onset of 
symptoms.^53^ 
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APPENDIX II 
STANDARD PROCEDURE FOR NEUROLOGIC EXAMINATION - STROKE UNIT 
Guidelines for Neurologic Examination 
1. Examinations are to be made hourly, if possible, but 
patients are not to be awakened from sleep routinely 
except at change of shifts. Unless specified otherwise, 
periods of sleep will be charted as "sleep." 
2. All estimations of level of responsiveness should be with 
reference to the previous examination. 
3. Functional Grade evaluation will be made at change of shifts 
on the basis of bedside nursing rounds attended jointly by 
both shifts of nurses. 
I. MENTAL STATUS 
The evaluation of MENTATION and LANGUAGE FUNCTION result from 
conversation with patients with questions specifically aimed at 
determining orientation in time, place, person; ability to perceive 
passage of time; ability to retain recent knowledge; capacity for 
abstract thinking. 
Mental Status Scoring: 
L.O.C. 
Fully Awake........100 
Awake, time disorientation, or mild confusion..._ 75 
Lethargic; or confusion, and time, place, person 
disorientation.... 50 
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Responds to deep pain stimulus only....25 
Co a... 0 
Seizures. S 
II. EXAMINATION SCHEME FOR APHASIA 
1. DYSPHASIA 
It is important before beginning the examination to ascertain 
whether the patient is suffering from confusion and if so, to what 
degree. Confusion results in defective comprehension and formula¬ 
tion of verbal symbols, the effect of which is to produce symptoms 
of dysphasia. Experienced observers may find it difficult to de¬ 
cide whether the amount of confusion presents sufficient evidence 
to account for the dysphasia observed. 
In order to avoid as far as possible the effects of fatigue, 
examination of speech function in a patient suspected of dysphasia 
should be conducted at a separate interview, which should not 
occupy more than 15 to 20 minutes. The patient should be com¬ 
fortable and at ease. The purpose of the tests should be ex¬ 
plained to him in appropriate terms. Failure should be glossed 
over by means of sympathy and encouragement. He should not be allowed 
to persist to the point of exasperation or despair over a test 
at which he has already shown himself inadequate. 
The simplest tests for routine use are as follows. The 
responses should be recorded in detail. They will indicate what 
tests might be of value in the further investigation of a given 
patient. 
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A. ABILITY TO UNDERSTAND SPOKEN WORDS 
The patient is given a series of verbal commands - the 
first should be "Close your eyes," then "Take hold of my 
hand." If these requests are promptly and correctly obeyed, 
more complicated commands are given, namely, "Touch your 
nose" and "Touch your left ear." If these commands are 
adequately carried out, the next should be "Touch your right 
ear with the index finger of your left hand." If this is 
correctly performed, he is told: "When I put both hands 
in my pockets, but not before, hold up your left hand." 
The examiner should be careful not to indicate by gestures 
the desired response. 
B. ABILITY TO UNDERSTAND WRITTEN WORDS 
A series of written commands should be presented to the 
patient in the order of increasing complexity. The 
command should first be written in legible handwriting. 
If there is failure, it should be repeated in block capitals. 
The commands are - 
Open your mouth. 
Put out your tongue. 
Put your hand on top of your head. 
Point to your left eye. 
Touch your right ear with your left thumb. 
When I lift my right hand above my head, 
but not before, pick up a pencil (a common 
object). 
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C. ABILITY TO EXPRESS HIMSELF IN SPEECH 
1. There is no formal test for this. It should be 
be observed and recorded. Note should be made of 
defective grammar and syntax, the occurrence of 
jargon and the capacity to finish sentences, as 
well as failure in the production of words. En¬ 
couragement to talk may be given in a variety of 
ways appropriate to the patient and his circumstances, 
ranging from "How are you today?"; "Where do you live?" 
to "Tell me about your accident"; ... "I hear you 
are interested in... (hobby or work); they tell me 
you are fond of ..." 
The examiner should behave naturally in this con¬ 
versation making use of expression and qesture to 
provoke a reply. 
2. Naming Objects: The patient is asked to name a 
series of common objects shown to him. Very slight 
degree of dysphasia may be revealed by these tests. 
The patient may name all objects correctly except 
one and that a very familiar one such as a pen, although 
able to describe it in terms of its use as "What you 
write with." 
The objects shown should be in the following order, those 
easily named being mingled with those more difficult: 
1. Penny 
2. Button 

90 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
Handkerchief 
Pencil 
Wrist watch 
Fountain pen 
Collar 
Tobacco pouch or cigarette case 
Counterpane or blotting paper 
Pin 
Cuff links 
Paper 
Toothbrush or waste paper basket 
Electric torch 
Ash tray 
D. ABILITY TO EXPRESS HIMSELF IN WRITING 
The patient is given pencil and paper and asked to write some 
account of the weather, of his own complaint, of recent news 
in the papers, or of the happenings of his daily life or previous 
occupation. 
APHASIA SCORING 
A. COMPREHENSION 
1. Understands language normally - 100. 
2. Able to point to objects named or written - not able to 
understand written language other than single names - 
Record as 75%. 
Able to distinguish RIGHT from LEFT side, able to carry 
out oral instructions requiring discrimination of side and 
3. 
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two other movements, i.e., close eyes, open mouth, hold 
up left arm or put left hand on right eye. Record as 50% - 
no ability to read. 
4. Follows simple oral instructions, i.e., open mouth, close 
eyes, but not able to read these instructions - not able 
to carry out two instructions, i.e., open mouth, hold up 
arm. Record as 25%. 
5. No comprehension of oral language - no ability to imitate - CL 
B. EXPRESSION 
1. Normal speech - 100 
2. Speaks in phrases but hesitates and gropes for words - 
Record as 75%. 
3. Names common objects correctly but unable to use phrases - 
Record as 50%. 
4. Says only "yes" or "no" appropriately and points to common 
objects correctly - Record as 25%. 
5. No oral speech or ability to write - CL 
III. MOTOR FUNCTION TESTING AND SCORING 
Motor function must be judged quantitatively, i.e.: 
Normal strength (100) 
Ability to hold limb elevated briefly (75) 
Ability to raise limb against gravity (50) 
Ability to move limb but not move it from bed (25) 
Paralysis or absence of all movement will be called (0) 
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IV. SENSORY FUNCTION TESTING AND SCORING 
A. Pin Stick 
Face ) 
) 
Arm ) Normal = TOO 
) 
) Altered= 50 
) 
Leg ) Absent = 0 
) 
B. Position Sense 
Hand ) Normal = 100 
) 
) Absent = 0 
) 
and ) Inaccurate appreciation of movement at 
) 
) slow rate = 75 
) 
) Appreciate movement at fingers only with 
) 
Foot ) wide range rapid movement = 50 
Appreciate movement at wrist not at 
fingers = 25 
C. DSS - Double Simultaneous Stimulation: Touch correspond¬ 
ing parts of body on right and left sides. 
1. If both sides are felt, record as R--L. 
2. If only right side is felt, record R/L. 
If only left side is felt, record L/R. 
D. Touch Localization: Compare ability to localize 
touch on affected side with ability on normal side. 
1. If results are the same, record 100%. 
2. If touch is located on correct parts of body, but 
not as precisely as normal side, record 75%. 
3. If touch is recognized on appropriate limb, but 
not more precisely, record 50%. 
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4. If there is ability recognize touch in the affected 
side of the body, but no ability to locate it, 
record 25%. 
5. If unable to recognize touch on affected side, record 0. 
E. Visual Fields Examination 
Monocular - unable to count fingers with either eye. 
Homonymous - unable to count fingers in one visual field. 
(or no response to threat in one visual field.) 
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